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ABSTRACT
Gamma-aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in 
the vertebrate brain. In the midbrain, GABAergic neurons contribute to the regulation 
of locomotion, nociception, defensive behaviours, fear and anxiety, as well as sensing 
reward and addiction. Despite the clinical relevance of this group of neurons, the 
mechanisms regulating their development are largely unknown. In addition, their 
migration and connectivity patterns are poorly characterized.
This study focuses on the molecular mechanisms specifying the GABAergic fate, and 
the developmental origins of midbrain GABAergic neurons. First, we have characterized 
the function of a zink-fi nger transcription factor Gata2. Using a tissue-specifi c mutagenesis 
in mouse midbrain and anterior hindbrain, we showed that Gata2 is a crucial determinant 
of the GABAergic fate in midbrain. In the absence of Gata2, no GABAergic neurons are 
produced from the otherwise competent midbrain neuroepithelium. Instead, the Gata2-
mutant cells acquire a glutamatergic neuron phenotype. Ectopic expression of Gata2 was 
also suffi cient to induce GABAergic differentiation in the chicken midbrain. Second, 
we have analyzed the midbrain phenotype of mice mutant for a proneural gene Ascl1, 
and described the variable and region-dependent requirements for Ascl1 in the midbrain 
GABAergic neurogenesis. These studies also have implications on the origin of distinct 
anatomical and functional GABAergic subpopulations in midbrain. Third, we have 
identifi ed unique developmental properties of GABAergic neurons that are associated 
with the midbrain dopaminergic nuclei, the substantia nigra pars reticulata (SNpr) and 
ventral tegmental area (VTA). Namely, the genetic regulation of GABAergic fate in 
these cells is distinct from the rest of midbrain. In accordance to this phenomenon, our 
detailed fate-mapping analyses indicated that the SNpr-VTA GABAergic neurons are 
generated outside midbrain, in the neuroepithelium of anterior hindbrain.
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11. Review of literature
1.1. Signal transduction in the central nervous system (CNS)
In the neuronal networks, signals are transmitted by passing on electrical currents within 
single cells. In contrast, cell-to-cell communication is primarily mediated by chemical 
signalling in specialized structures called synapses. The molecules used in synaptic 
signal transduction, neurotransmitters, are released by an activated presynaptic cell and 
can either potentiate (excitation) or prevent (inhibition) electrical activation in another, 
postsynaptic cell, which possesses receptors for these neurotransmitters. In the silent 
neurons, cell membrane is polarized at a resting membrane potential of ca -65 mV. This 
resting potential is established by maintaining different concentrations of electrically 
charged ions inside and outside of the cells. The most relevant in synaptic signalling are 
the differences in Na+, K+ and Cl¯ concentrations so that the Na+ and Cl¯ concentrations 
are maintained higher outside while K+ concentration is higher inside the cell.
During signalling at the synapse, neurotransmitters bind to their receptors, which 
either directly (in case of ionotropic receptors) of indirectly (metabotropic receptors) 
causes opening of transmembrane ion channels selective for one or several of the ions 
mentioned above, as well as Ca2+. While the ionotropic receptors are ligand-gated ion 
channels, whose activity directly depends on the neurotransmitter binding, the metabotropic 
receptors are typically G-protein coupled transmebrane proteins. Neurotransmitter 
binding to the metabotropic receptor activates a downstream intracellular signalling 
cascade that can then result in opening of transmembrane ion channels and/or the release 
of Ca2+ from intracellular storages, thereby changing membrane potential. Opening of 
the transmembrane channels allows ions to fl ow across neuronal membrane, down their 
concentration gradients, bringing the membrane closer to electrical equilibrium potential 
for that particular ion. This results in membrane depolarization in the case of Na+ or Ca2+ 
and hyperpolarization for K+ or Cl¯ fl ow.
1.2. GABA mediated signalling in the adult CNS
GABA is the main inhibitory neurotransmitter in adult mammalian CNS. Inhibition is 
crucial for the normal brain function, coordinating and balancing excitatory activity. 
Inhibitory effect of GABA on neuronal signalling is mediated by the GABA receptors that 
in essence prevent depolarization of the neuronal membrane, lowering basal activity of 
the neuron. There are two types of GABA receptors: ionotropic GABA-A and GABA-C 
receptors are voltage gated Cl¯ channels that upon binding GABA allow Cl¯ ions to fl ow 
inside the cell; while activation of metabotropic, G-protein coupled GABA-B receptors 
results in opening of K+ channels and thus prevents depolarization by allowing K+ effl ux 
(Inoue et al., 1985; Turner and Whittle, 1983).
Inhibitory neurons producing GABA are found in almost all regions of the CNS. 
Despite the rather standard synaptic effects they mediate, these cells are highly variable 
in their gene expression, morphology, projection patterns and functional output 
(see overview by Petilla Interneuron Nomenclature Group et al., 2008). GABAergic 
circuits are at the basis of processes affecting sleep and wakefulness, epilepsy, anxiety, 
bipolar disorder and addiction, to name just few examples. Disruption of GABAergic 
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2neurotransmission, for example by mutagenesis in experimental animals, typically 
results in spontaneous seizures, increased sensitivity to pain, and various behavioural 
abnormalities (Schuler et al., 2001).
1.3. GABA and developing neurons
The functions of GABA are quite different, and more varied during development, 
exceeding from the synaptic neurotransmission that it mediates in mature circuits. 
Importantly, the postsynaptic response to GABA signals in the immature brain, as 
opposed to the mature networks, can be also excitatory, meaning that the GABA-
induced Cl¯ currents exert a depolarizing effect on the developing neurons (Ben-Ari et 
al., 1989; Serafi ni et al., 1995). This opposite effect arises due to the differences in the 
transmembrane ionic balance in developing versus mature neurons. In immature neurons, 
the intracellular Cl¯ concentration is higher than in the mature neurons. This is due to the 
presence of Na-K-2Cl cotransporter (NKCC1) in the neuronal membrane, which imports 
Cl¯ ions (Khirug et al., 2008), but lack of a simultaneously acting Cl¯ extrusion system. 
In such conditions, electrochemical gradient drives Cl¯ ions out of the cell, making 
the Cl¯ current depolarizing. During postnatal development, as neurons acquire more 
mature membrane properties, the ionic balance is changed so that the effect of GABA 
is switched from depolarizing to hyperpolarizing (Figure 1A, Rivera et al., 2005). This 
change in the balance of Cl¯ ions correlates with the appearance of a Cl¯-extruding 
cotransporter, potassium-chloride-cotransporter-2 (KCC2) that starts to be expressed 
in neuronal cell membrane during the fi rst two postnatal weeks in rats (Rivera et al., 
1999). The depolarizing (excitatory) activity of GABA during development is thought 
to be important for circuit formation, by generating synchronous activity in developing 
neuronal networks (giant depolarizing potentials; Ben-Ari et al., 1989; Sipila et al., 
2005), but also modulating other aspects in circuit formation, like neuronal migration. 
The effect of GABA on cortical neuron migration has been shown to be concentration 
dependent and mediated by intracellular Ca2+ (Behar et al., 1996) and has also been 
demonstrated in vivo (Heck et al., 2007).
In addition to its facilitator role in developing neuronal networks, signalling via 
GABA-A receptors has been implicated in the regulation of proliferation in embryonic 
and neural stem cells, as well as regulation of cell numbers and growth of early embryos. 
This function seems to be directly linked to cell cycle progression, as GABA receptor 
activation leads to rapid activation of histone variant H2AX, a component of post-DNA 
replication checkpoint complex (Andang et al., 2008). GABA-induced depolarizing Cl¯ 
currents have been shown to inhibit the DNA synthesis in neuronal progenitors also in 
later stages of development, using embryonic cortical slices. In contrast to stem cells, the 
effect on proliferation at later embryonic stages seems to be associated with the increase 
in intracellular Ca2+ (LoTurco et al., 1995).
In conclusion, GABA appears to  serve as a multifunctional signalling agent in the 
developing brain, regulating proliferation, differentiation, gene expression (including 
GABA receptors themselves), migration, circuit formation and synaptogenesis (Figure 
1B; reviewed in Ben-Ari, 2002; Ben-Ari et al., 2007; Owens and Kriegstein, 2002; Wang 
and Kriegstein, 2009).
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31.4. GABAergic neurons in the midbrain
Alike in the CNS in general, GABAergic neurons are found widespread in the midbrain. 
However, specifi c spatial and functional subgroups can clearly be distinguished: in 
superior and inferior colliculi (collectively known as midbrain tectum), periaqueductal 
gray (PAG), midbrain reticular formation (mRF) and substantia nigra pars reticulata 
(SNpr). In the dorsal midbrain, GABA neurotransmission is involved in the visual 
information processing in superior colliculi (SC) (Binns and Salt, 1997). Well-studied 
examples of SC functions are the saccadic eye movements and multisensory and motor 
processing (King, 2004; McHaffi e et al., 2005). The inferior colliculi (IC) are an important 
centre of auditory processing, and contain also a substantial number of GABAergic 
neurons which, besides local processing, contribute to tectothalamic outputs (Ito et al., 
2009). In the PAG, GABAergic neurons constitute the main active circuit, providing 
constant tonic inhibition on all pathways in this region, controlling fear and anxiety, 
the related autonomic regulation and vocalizations, pain processing, nociception, and 
sexual behaviour (Behbehani, 1995). Distinct defensive behaviours can be functionally 
linked to distinct subdivisions of PAG: activation of more dorsal regions triggers active 
defence, so-called “fi ght-or-fl ight” behaviours and increase in heart rate, while ventral 
subdivisions mediate passive protective response, freezing and hypotension. In addition, 
dorsal PAG (dPAG), integrated with deep layers of SC and IC, is involved in processing 
aversive stimuli, fear associated with novel cues, and anxiety (Brandao et al., 1999). The 
GABAergic neurons in ventrolateral (vl) PAG are especially important in conditioned 
fear response (Brandao et al., 2005; Brandao et al., 2008); and together with midbrain 
reticular formation also regulate sleep and wakefulness (Fort et al., 2009; Sapin et al., 
Figure 1. A, Opposite effects of Cl¯ channel opening to membrane potential in developing 
and mature neurons. The switch from depolarizing to hyperpolarizing effect of Cl¯ currents 
during development correlates with the upregulation of Cl-extruding pump KCC2. B, GABA 
signals are involved in multiple steps of neuronal differentiation. GABA-induced depolarizing 
currents suppress proliferation and promote neurogenesis. Depolarizing GABA signals promote 
cortical interneuron migration, while hyperpolarization provides a signal to stop migration and 
integrate in the cortex. GABA signalling also promotes neuronal maturation and establishment 
of connectivity. See text (chapter 1.3.) for more detailed examples. [Cl-], chloride concentration; 
CP, cortical plate; MZ, marginal zone; VZ, ventricular zone; SVZ, subventricular zone. Adapted 
from Blaesse et al., 2009; Rivera et al., 2005; Wang and Kriegstein, 2009.
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42009). The midbrain reticular formation contains a considerable number of loosely 
organized GABAergic neurons that are functionally poorly described.
1.4.1. VTA and SN GABAergic neurons
The most ventral GABAergic neurons found in midbrain are associated with midbrain 
dopaminergic nuclei in substantia nigra (SN) and VTA. The functions of dopaminergic 
(DA) neurons in VTA and SN pars compacta (SNpc) have been extensively studied, as 
they are an important part of the movement regulation pathways of basal ganglia (in 
SNpc) as well as regulators of mood and motivation (in VTA). In addition to the DA 
neurons, there is a substantial number of GABAergic cells in the ventral midbrain nuclei, 
which have not received the same enthusiastic attention. Nevertheless, the GABAergic 
neurons in these areas are a major group of targets for both neuropharmacology (Foster 
and Kemp, 2006) as well as drugs of abuse (Laviolette and van der Kooy, 2004b; Tan et 
al., 2010).
In the SN, GABAergic cells are located in its ventrolateral part, the pars reticulata, 
which is almost completely composed of GABAergic projection neurons. SNpr constitutes 
the major output centre of the basal ganglia, with efferent connections to thalamus, 
superior colliculus and brainstem, as well as local axon collaterals to dopaminergic 
neurons in SNpc and thus SNpr shares an important function in initiation, planning and 
execution of motor behaviour (Deniau et al., 2007; Tepper and Lee, 2007). In VTA, 
approximately one-third of the cells are GABAergic (Carr and Sesack, 2000). These 
cells contribute to the local circuits, regulating the activity of VTA DA neurons, but also 
constitute projection neurons to prefrontal cortex (PFC), nucleus accumbens and several 
limbic areas, the circuits underlying positive reward and conditioned learning processes 
(Fields et al., 2007). A highly interesting GABAergic neuron population has recently been 
identifi ed in the caudal portion of VTA, termed “tail of VTA” or rostromedial tegmental 
nucleus (RMTg). The GABAergic neurons in RMTg are activated in response to 
psychostimulants, like cocaine, and preferentially project on VTA DA neurons (Kaufl ing 
et al., 2010). Further analysis has shown an important role of RMTg in encoding aversive 
stimuli, and the behavioural responses to such stimuli by modulating DA neuron activity 
in the VTA (Jhou et al., 2009a). Consistently to this function, RMTg receives afferents 
from other brain areas associated with aversive stimuli and reward processing, like lateral 
habenular nucleus. In addition, both afferent and efferent projections link RMTg with 
several brainstem regions associated with emotional processing, behaviour and learning 
(Jhou et al., 2009b).
Biochemically diverse phenotypes can be distinguished within both SNpr 
(Gonzalez-Hernandez and Rodriguez, 2000) and VTA GABAergic neurons (Olson and 
Nestler, 2007), and these subdivisions can have distinct functional properties (reviewed 
in Deniau et al., 2007; Fields et al., 2007).
1.5. Neuronal diversity and fate specifi cation in CNS
There are large number of distinct neuronal subtypes in the CNS, classifi ed by their 
morphology, projection patterns, electrical and chemical (neurotransmitter) properties. 
Neuronal cells of different phenotype can be generated from either spatially distinct 
progenitor populations or, alternatively, from the same region, but during different 
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5time periods. Aside the enormous diversity that stems from a relatively homogenous 
progenitor population, the overall number of cells in CNS is also greatly expanded 
during the embryonic development. Both the expansion in cell numbers (proliferation of 
progenitors) and the differentiation of neurons (neurogenesis) take place simultaneously 
in the developing brain. Therefore, to eventually achieve a brain of correct size and 
morphological and functional composition, tight control over the proliferation and 
differentiation of developing neuronal precursors is essential.
1.5.1. Development and organization of the neural tube
All the neurons and glia in the adult brain are ultimately derived from the multipotent 
neuronal stem cells/progenitors forming the neuroepithelium, which constitutes the walls 
of the embryonic structure called the neural tube. The neural tube is a tubular structure 
formed by folding of the neuroepithelial tissue established at gastrulation (Beddington 
and Robertson, 1999). With the gastrulation, the cells of the embryo are segregated into 
the three germ layers (ecto-, meso- and endoderm), and the anteroposterior (AP) axis 
is established. At the end of gastrulation, part of the mesoderm cells aggregate to form 
a tubular condensate, the notochord, which serves to defi ne the midline of the embryo. 
The neural tissue is specifi ed from the midline ectoderm in response to the instructive 
signals provided from the embryonic primary organizer and other surrounding tissues 
Figure 2. Neural induction and neural tube formation. Schematic representation of chicken 
embryos; upper images: dorsal view, bottom images: cross-section, the section plane is shown 
with the dotted line on upper images. A, Prior the gastrulation (blastula stage), prospective neural 
tissue can be identifi ed by the Sox3 expression in the epiblast. Sox proteins are required for the 
competence to respond to further inductive signals, like Fibroblast growth factor (FGF) from the 
underlying hypoblast. B, During gastrulation, the node serves as the primary embryonic organizer 
for neural tissue, providing inhibitors of BMP (Bone morphogenetic protein) and Wnt signalling. 
Black arrows indicate the inductive signalling events. Grey block arrows in the lower panel 
indicate the ingression of prospective mesodermal cells during gastrulation. C, Neural plate folds 
to form the neural tube; fore-, mid- and hindbrain vesicles are indicated. Neural tube patterning 
is regulated by dorsalizing factors (BMP) emanating from the dorsal epidermis, and ventralizing 
factors (Sonic Hedgehog, Shh) from the notochord.
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6(reviewed by Saxen, 1989; Stern, 2005; Vieira et al., 2010) (Figure 2A,B). However, 
the competence to respond to these instructive signals may already be encoded in the 
presumptive neuroepithelial cells prior gastrulation (by the expression of Sox proteins, 
see 1.5.3a.) (Wilson and Edlund, 2001). The induced neuroepithelial sheet (neural plate) 
invaginates and folds to form the neural tube, which, as it grows, segregates into the 
major brain compartments: fore-, mid-, and hindbrain and spinal cord (Figure 2C). The 
following development of different compartments is controlled by signals from local 
secondary organizers typically established at compartmental interfaces (reviewed by 
Echevarria et al., 2003).
1.5.2. Patterning of the neural tube
Neuroepithelial cells are patterned already at the progenitor stage by combinatorial 
expression of a multitude of transcription factors (TFs) in regionally restricted patterns, 
which gives cells unique identities depending on their exact position in the neural tube. 
Vertebrate spatial patterning genes typically contain homeobox sequences that encode 
for the homeodomain motifs necessary for DNA recognition and the regulation of target 
gene expression.
1.5.2a. Anterior-posterior patterning of the neural tube
Neuroepithelial cells acquire distinct identities along the anteroposterior (AP) axis at 
the gastrulation stage, instructed by signals from adjacent non-neuronal tissues (Figure 
2). Graded Wingless-related (Wnt) activity in combination with FGF signals appear 
to be suffi cient to segregate the neural plate cells into the major AP compartments in 
consequent order (Nordstrom et al., 2002; Figure 3A). In addition, these early patterning 
events seem to encode the competence of cells to form the secondary signalling centre 
at the midbrain-hindbrain border (MHB) (Olander et al., 2006), the isthmic organizer 
(IsO).
In developing CNS, the earliest genes expressed differentially and in a regionally 
restricted manner along the AP axis are homeodomain (HD) TFs Otx2 and Gbx2, 
bordering at the midbrain (MB) and anterior hindbrain (rhombomere 1, r1), respectively. 
The expression of Otx2 and Gbx2 ultimately defi nes the MB and r1 territories and is 
crucial for the positioning of the IsO at their interface (Broccoli et al., 1999; Hidalgo-
Sanchez et al., 2005; Millet et al., 1999). Subsequently, a set of intercellular signalling 
molecules are expressed within the neural tube. Fgf8 and Wnt1 released from IsO act as 
master regulators in patterning the MB-r1 territory (reviewed by Nakamura et al., 2005). 
IsO-derived signalling molecules selectively control the expression of, as well as receive 
regulatory feedback from a multitude of HD transcription factors. For instance, Fgf8 
induces the expression of En1, En2 and Gbx2, and represses Otx2 and Pax6 expression to 
regulate the morphogenesis of midbrain and cerebellum structures (Puelles et al., 2004). 
The capacity of Fgf8 to induce these distinct structures, however, depends on previously 
established competence of the signal-receiving cells. For example, the instructing signals 
from Fgf8 seem to require Otx2 to be properly interpreted into positional information 
in the midbrain cells (Puelles et al., 2004). In the hindbrain, the expression of Irx2 in r1 
precedes the formation of IsO. Later, modulation of Irx2 activity by IsO-derived Fgf8 
is required for the development of cerebellum, the major derivative of dorsal r1 (Figure 
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73B; Matsumoto et al., 2004). Upon FGF-mediated activation, Irx2 is involved in the 
reorganization of Otx2, Gbx2 and Pax2 expression and thus in the fi ne positioning of 
IsO (Matsumoto et al., 2004). 
Another feedback regulation loop acting in both mb and r1 involves Fgf8, En and 
Pax TFs (Figure 3B). En proteins are involved in the activation of Pax5 and inhibition of 
Pax6 expression. At the same time, conserved paired-box binding sites have been found 
in En2 upstream enhancer, and these Pax binding sited are required for Fgf8 to maintain 
En2 expression in MB-r1 region (Liu and Joyner, 2001). This regulation is important 
for maintaining En2 expression after its initial onset, which is independent of Pax (Liu 
and Joyner, 2001). Pax2-mediated regulation of Brn1 (Pou3f3) expression could provide 
feedback inhibition of Fgf8 in the MHB, restricting its expression strictly to anterior-
most hindbrain and preventing it in more caudal cells (Simon et al., 2005).
Figure 3. Interactions of major 
morphogens and transcription 
factors involved in the 
anteroposterior (AP) patterning 
of midbrain-rhombomere 1 
area. A, Crude AP patterning 
of the neural plate by FGF and 
Wnt gradients at gastrulation. 
B, Positioning and patterning 
activities of the isthmic 
organizer (IsO).  At fi rst, Otx2 is 
expressed anterior and Gbx2 posterior to prospective mid-hindbrain boundary. Otx2 and Gbx2 
cross-antagonize each other and establish the IsO area at their expression border, which will 
express Fgf8. The Fgf8 expression and IsO region is further refi ned by interactions of Fgf8 and 
pre-patterning transcription factor Irx2. Fgf8 signal from the IsO is required for the development 
of midbrain (MB)-rhombomere 1 (R1) structures. Fgf8 signalling from IsO induces the expression 
of En and Pax 2/5, which form a positive feedback loop to promote each other’s expression. In 
addition, En represses the forebrain (FB) determinant Pax6 expression posterior to diencephalon 
(Di)-midbrain border.
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1.5.2b. Dorsal-ventral patterning of the neural tube
Concerning the cellular diversity within a single brain compartment, the DV patterning 
is of notable importance. The central morphogens in basal midbrain and r1 patterning 
are Sonic hedgehog (Shh) that is released from the fl oor plate (Agarwala et al., 2001; 
Ericson et al., 1995); bone morphogenetic proteins (BMP) from the overlying ectoderm 
and Wnt signals from the roof plate (Wurst and Bally-Cuif, 2001). In the midbrain, Shh 
establishes distinct DV domains by activating its downstream transcriptional activator 
Gli2 in the ventrolateral midbrain and restricting the Gli3 repressor function to the 
lateral-dorsal areas (Figure 5A) (Blaess et al., 2006).
The actions of Shh in neuroepithelial patterning and the specifi cation of neuronal 
subtypes are best exemplifi ed in the development of spinal cord. During the patterning 
of the ventral spinal cord, Shh is released from the notochord and fl oor plate (Marti 
et al, 1995). Graded Shh signalling then regulates the expression of an array of target 
8genes that pattern and specify distinct populations of ventral neurons. Shh target genes, 
which typically encode HD family transcriptional repressors, can respond to certain 
levels of signalling, and they can either be repressed (class I) or activated (class II) by 
Shh (Briscoe et al., 2000; Ericson et al., 1997). Shh target genes are initially expressed 
in broad domains, which are thereafter rapidly refi ned. This refi nement involves cross-
repression between class I and class II Shh targets at the domain boundaries (Briscoe et 
al., 2000). Thus, in the ventral spinal cord, graded Shh morphogen activity is translated 
into a HD TF code that defi nes distinct progenitor populations separated by sharp 
domain boundaries (Figure 4; reviewed in Briscoe and Novitch, 2008; Briscoe, 2009). 
Subsequently, the expression of proneural genes follows these boundaries, and distinct 
neuronal fates arise from each progenitor domain. In the neuronal subtype specifi cation, 
HD proteins can act synergistically with the proneural gene function. For example, 
bridging the LIM-HD TFs Lhx3 and Isl1 to the proneural protein NeuroM via an adaptor 
protein NLI increases the effi ciency of ventral motor neuron differentiation (Lee and 
Pfaff, 2003). This interaction provides a direct link between a HD code and neuronal fate 
specifi cation in the neural tube.
Similar model of HD code of neuronal progenitors has recently been depicted 
for mouse midbrain (Nakatani et al., 2007). In this model, at least seven distinct DV 
domains can be identifi ed based on their expression of distinct combinations of HD 
proteins Lmx1a, Foxa2 (HNF3β), Nkx2-2, Nkx6-1 and Pax7 (Figure 5A). The function 
of Shh in the establishment of midbrain HD protein expression has been extensively 
studied in chicken model, where Shh can induce the full ventral gene expression pattern, 
so-called “midbrain arcs”, in correct orientation respective to the Shh source (Agarwala 
et al., 2001), and also repress dorsal gene expression (Bayly et al., 2007). 
Figure 4. DV patterning in the ventral spinal cord is controlled by Shh gradient. Shh is released 
from the notochord and fl oor plate. Shh represses the expression of its Class I target genes, while 
inducing the Class II targets. Subsequently, Class I and II transcription factors counter-repress 
each other, refi ning distinct progenitor domain boundaries in ventral spinal cord. Each progenitor 
domain expresses characteristic set of Shh target genes and gives rise to distinct neuronal subtypes. 
p0-3, interneuron progenitor domains along the DV axis. V0-3, distinct classes of interneurons 
derived from the respective progenitor domains. pMN, motor neuron progenitor domain; MN, 
ventral spinal cord motor neurons. Adapted from Briscoe, 2009.
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characterized by the expression of Nkx2-2, Nkx6-1, Pou4f1, Pax6 or Lhx1/2 (Nakatani 
et al., 2007). The HD protein expression can also be linked with different midbrain 
nuclei later arising from these DV domains (Agarwala and Ragsdale, 2002; Bayly et al., 
2007) and neuronal subtypes within these nuclei (Figure 5B; reviewed by Puelles, 2007).
1.5.2c. Integration of AP and DV patterning in midbrain
IsO-derived molecules alone as well as in various combinations are involved in highly 
integrated AP and DV patterning in the midbrain and r1 neuroepithelium. For example, 
the cellular competence in responding Shh signals can be modulated by Otx2 (Puelles 
et al., 2004), Fgf8 and Wnt1 (Joksimovic et al., 2009b; Prakash and Wurst, 2006). Otx2 
has also been implicated in the restriction of Shh expression domain, thus affecting the 
development of ventral midbrain dopaminergic and glutamatergic neurons (Puelles et 
al., 2003). Later in development, Otx2 may also regulate neuronal subtype selection via 
activation of proneural proteins (Vernay et al., 2005). Thus, a complex and recursively 
wired patterning network is established in the neural tube early in development, specifying 
the competence of the individual progenitor cells in different position (reviewed in 
Prakash and Wurst, 2004; Wurst and Bally-Cuif, 2001).
1.5.3. Regulation of neurogenesis
Neuroepithelial cells within the neural tube are well organized according to their cell 
cycle progression and differentiation status. The proliferative neuroepithelial cells are 
Figure 5. Dorsoventral homeodomain (HD) protein code in the vertebrate midbrain can be 
associated with distinct neuronal subtypes generated in each domain. A, HD transcription factor 
code is established by graded Shh signalling, which is translated into changing levels of Gli2 
activator (A) and Gli3 repressor (R) along the DV axis. Seven DV domains (m1-m7) can be 
distinguished in the midbrain neuroepithelium. Characteristic expression of patterning genes 
in m1-m7 is indicated for the ventricular zone (VZ; progenitor cells) and marginal zone (MZ; 
postmitotic neurons). Neuronal subtypes arising from each midbrain domain are also indicated. 
B, Schematic representation of prenatal (E18.5) mouse midbrain showing the neuronal nuclei 
originating from midbrain neuroepithelium. Modifi ed from Puelles, 2007.
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lined near the lumen (apical side) where they form a layer called the ventricular zone 
(VZ). Differentiating cells exit the cell cycle, i.e. become postmitotic, lose connection 
with the luminal surface and move into the outer layer called the marginal zone (MZ), 
along their basal process. The proliferative cells in ventricular zone possess connections 
with both the apical and basal surfaces of the neural tube. The position of the nucleus 
of these highly elongated cells depends on the stage of cell cycle: The cell division 
(i.e. mitosis and cytokinesis) takes place at the apical surface. During the G1 phase 
the nuclei migrate towards the basal side of the VZ, where the DNA replication (S 
phase) takes place. Finally, during G2 the nuclei move back apically. This movement, 
called interkinetic nuclear migration (INM), might be coupled with neurogenesis as, 
apparently, certain cell fate selection factors (e.g. Notch receptors and targets, see 1.5.3c) 
seem to be expressed in higher levels at the apical than in basal side of ventricular zone 
(Henrique et al., 1997; Lindsell et al., 1996). Consistently, disturbances in INM can 
affect the proliferation of neuronal progenitors and prolonged stay in the basal region, 
where Notch signalling is less active, can trigger premature differentiation (Del Bene et 
al., 2008). Furthermore, the Notch mRNA has been shown to be stabilized in G2/M/G1 
phase and less stable in S-phase cells (Cisneros et al., 2008). Oscillations in the mRNA 
levels of Notch target genes have also earlier been observed in dividing neuroepithelial 
cells (Hirata et al., 2002). 
In addition to Notch, FGF and Epidermal growth factor (EGF) signalling is also 
important for the neuronal stem cell identity. In the neuroepithelium, FGF signalling 
promotes undifferentiated status in neuronal progenitors (Akai et al., 2005; Bertrand et 
al., 2000). In the absence of FGF signalling, the neuronal progenitors in ventral midbrain 
undergo premature cell cycle exit, resulting in the depletion of progenitor pool and the 
loss of midbrain ventral cell types, like DA neurons (Saarimaki-Vire et al., 2007).
1.5.3a. Neuronal progenitor identity: SoxB1 family
The earliest known markers of neural identity in a developing embryo are the Sox (SRY-
like HMG box) TFs of the SoxB1 subgroup, Sox1-3. Already prior gastrulation, Sox2 is 
expressed in the presumptive neuroectoderm, where it contributes to the responsiveness 
to the neural induction by FGF (Mizuseki et al., 1998) and inhibitors of BMP (Kishi et 
al., 2000). Shortly after gastrulation, the expression of Sox2 and Sox3 becomes restricted 
to the forming neural tissue (Rex et al., 1997; Wood and Episkopou, 1999). In the neural 
tube, Sox1-3 expression maintains the undifferentiated status of neural progenitors 
(Bylund et al., 2003; Graham et al., 2003), and this function appears independent or 
complementary to that of Notch signalling (Holmberg et al., 2008). While the Notch 
target Hes prevents neurogenesis by repressing proneural gene expression, Sox3 is able 
to prevent differentiation even in the presence of a proneural protein Ngn2 (Bylund 
et al., 2003). While Sox1-3 preserve progenitor status, neurogenesis is promoted the 
transcriptional repressors of SoxB2 subgroup, Sox14 and Sox21 (Uchikawa et al., 1999). 
The SoxB1 and SoxB2 TFs apparently regulate a similar set of target genes, and the co-
expression of Sox21 and Sox3 can have different effect to the neurogenesis in the chicken 
neural tube, depending on the ratio of the factors (Sandberg et al., 2005). Thus, for the 
neurogenesis to occur, the SoxB1 activity must be counteracted by SoxB2 subgroup TFs.
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1.5.3b. Commitment to neuronal fate: proneural genes
Neuronal differentiation is thought to be triggered by so-called proneural genes. 
Vertebrate proneural genes code for basic domain-helix-loop-helix (bHLH) transcription 
factors that can instruct neuroepithelial cells to exit cell cycle and commit to a neuronal 
fate (Lee et al., 1995). To elicit their function, bHLH proteins form a heterodimeric 
complex with ubiquitously expressed E-proteins, typically E2A gene variants E12 and 
E47 in neurons. The proneural bHLH-E-protein complex binds DNA at a consensus 
sequence, CANNTG, generally known as E-box, and thus activates the expression of 
genes related to neuronal differentiation (Massari and Murre, 2000). In addition to 
directing cells to postmitotic neuronal fate in general, at least in some cases proneural 
genes seem to be coupled with certain neuronal fates. For example, Ascl1 drives the 
GABAergic, and Ngn2 the glutamatergic neuron differentiation during the mammalian 
cortex development (Fode et al., 2000; Parras et al., 2002). The ability of proneural TFs 
to drive neuronal subtype commitment may, at least in part, be regulated in the level 
of the target gene activation, either via the binding partners of proneural proteins or by 
physical interaction with the DNA. Although the bHLH-E-protein complex is capable of 
DNA binding, it may not be suffi cient to initiate transcription. Typically, cofactors are 
needed for the target gene activation, and variation in the expression and/or activity of 
these factors can give cells different competence to respond to certain proneural signal 
(Lee and Pfaff, 2003). Enhancers can exhibit different binding affi nities to different 
transcription factors, even if these are very closely related (Castro et al., 2006). Thus, 
proneural proteins can exert their function in diverse manners, depending on their 
cofactors, transcriptional regulatory regions of the target genes and the pre-patterned 
competence of the cell (reviewed in Guillemot, 2007; Powell and Jarman, 2008).
1.5.3c. Maintenance of the progenitor pool: lateral inhibition
As proneural factors trigger differentiation, it is crucial to simultaneously maintain a 
certain pool of stem cells until the complete spectra of neurons have been generated. 
To avoid depletion of the progenitor pool, the differentiating neurons are utilizing a 
lateral inhibition mechanism mediated by Notch signalling. Notch signalling cascade 
is triggered by the proneural proteins, which induce the expression of Notch ligand, 
Delta, on the cell surface (Kunisch et al., 1994). Delta can then interact with Notch 
receptor on the neighbouring cells, triggering proteolytic cleavage of Notch and nuclear 
translocation of the Notch intracellular domain (Bray, 2006). Nuclear Notch intracellular 
domain activates the transcription of target genes, including the bHLH transcriptional 
repressors of Hes family. Hes proteins effi ciently repress proneural genes and maintain 
a proliferative “stem cell” state (Chen et al., 1997; Ishibashi et al., 1995; Kageyama et 
al., 2007). Therefore, the levels of Hes and thus also the levels of proneural activity in 
neuronal progenitors vary according to the levels of Delta expressed by the neighbouring 
cells. Considering also the link between Notch activity and INM (chapter 1.5.3), cells 
with different neurogenic potential can be spatially distinguished in VZ (Latasa et al., 
2009): For one, the S-phase cells with basally localized nuclei express high levels of 
proneural genes and thus gain neurogenic competence. In the G1/M/G2 phase (cells 
with apically localized nuclei), this competence can be realized by neurogenic division 
and cell cycle exit. However, at the same time, the neurogenic potential can also be 
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effi ciently suppressed, as the neuronal progenitors in the apical VZ receive higher levels 
of Notch signalling. This cycle makes the expression of proneural genes oscillatory and 
not an explicit indicator of neurogenesis for a particular cell (Kageyama et al., 2009). 
In short, proneural genes, via Delta-Notch signalling, induce a self-regulatory feedback 
loop that enables, through iterations and stochastic selection, to trigger neurogenic cell 
cycle exit in limited number of progenitors despite of their rather ubiquitous expression 
(Bertrand et al., 2002; Kageyama et al., 2005; Kageyama et al., 2007).
The functions of Notch signalling can exceed from its best-known role in lateral 
inhibition (reviewed by Cau and Blader, 2009). For instance, Notch has been implicated 
in binary fate decision in vertebrate CNS, during the excitatory versus inhibitory 
interneuron fate selection in mouse spinal cord (see chapter 1.6.3.).
1.5.3d. Neuronal subtype specifi cation in proliferating progenitors
Although the expression of proneural genes can be spatially restricted, proneural activity 
generally activates pan-neuronal genes and further regulation of neuronal fate involves 
additional subtype specifi cation factors. The subtype specifi cation factors often, but 
not exclusively belong to bHLH family, and these TFs can both activate and repress 
particular target genes (Guillemot, 2007). For example in the ventral forebrain, Ascl1 
and homeobox TF Dlx1/2 are independently expressed in the VZ and subventricular zone 
(SVZ), and required for different aspects of neurogenesis (Yun et al., 2002). While Ascl1 
seems to regulate the timing and extent of the production of late progenitors or early 
precursors in the SVZ (Casarosa et al., 1999; Yun et al., 2002), the Dlx1/2 are required 
for the generation of postmitotic GABAergic interneurons from the SVZ progenitors 
(Anderson et al., 1997b; Yun et al., 2002).
In the midbrain, the expression of bHLH family transcriptional repressor Helt is 
induced independently of Ascl1 in the GABAergic progenitor domains (Miyoshi et 
al., 2004), and its expression is required for GABAergic neurogenesis (Guimera et al., 
2006b). Apparently, Helt supports the GABAergic fate commitment by suppressing the 
glutamatergic neurogenesis (Nakatani et al., 2007) (discussed in more detail below).
Thus, in the neural tube, different classes of TFs must act synergistically to specify distinct 
progenitor domains and neuronal subtypes therein. In this cascade, both proneural genes 
and other bHLH TFs apparently lie downstream of the HD TF code (Guillemot, 2007).
1.5.3e. Subtype specifi cation in postmitotic neurons
The subtype specifi cation factors can act as sole promoters or inhibitors of certain cell 
fate, or function in both directions, driving multipotent neuronal precursors towards a 
specifi c subtype, simultaneously preventing expression of genes characteristic to other 
cell types. Such bimodal regulators are called selector genes; and a few of them have been 
characterized in the selection of GABAergic versus glutamatergic neuron phenotype in 
the mammalian CNS. For example, bHLH TF Ptf1a controls GABAergic as opposed 
to glutamatergic fate selection in both mammalian cerebellum and dorsal spinal cord 
(Glasgow et al., 2005; Hoshino et al., 2005; Pascual et al., 2007) (see 1.6.2a and 1.6.3a). 
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At the same time, HD proteins Tlx1 and Tlx3 are both required as well as suffi cient for 
the induction of glutamatergic neurogenesis in the expense of GABAergic neurons in the 
dorsal spinal cord, thus acting as selectors for the glutamatergic fate (Cheng et al., 2004; 
Cheng et al., 2005).
In summary, combined expression of proneural, subtype specifi cation and/or 
selector genes in the neuroepithelium enables different types of neurons to be produced 
in a simultaneous manner and contributes to the diversity of cell types found in the adult 
brain (Figure 6).
Figure 6. The genetic regulatory events controlling neurogenesis.
Neural progenitor identity and self-renewing status is maintained by FGF, Wnt and SoxB1 (blue) 
family TFs. Neurogenic cell cycle exit is triggered by proneural factors. Proneural factors also 
initiate lateral inhibition cascade via Delta-Notch signalling, promoting the maintenance of 
undifferentiated status in neighbouring cells. SoxB2 (blue) TFs suppress progenitor identity in 
the postmitotic neuronal precursors. Additional subtype specifi cation factors (red) further refi ne 
the subtype identity of newborn neuronal precursors.
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1.6. GABAergic neurogenesis
Preceding the neurogenesis, brain compartments are subjected to distinct regional 
patterning cues from the adjacent tissues as well as local signalling gradients (reviewed 
above). Therefore, it is perhaps not surprising that the cellular competence and neurogenic 
potential differs between the compartments. Indeed, the molecular mechanisms 
regulating the development of GABAergic neurons vary greatly between different brain 
regions (Table 1).
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Table 1. Genes involved in the GABAergic neuron development in different brain regions.
     Func-
       tion
Brain
region
Spatial patterning:
HD proteins
Proneural:
bHLH proteins
Progenitor
specifi cation:
HD or bHLH
Postmitotic
subtype specifi ca-
tion:
bHLH,
GATA (midbrain)
Forebrain
Shh: Nkx2-1 (MGE)
(Sussel et al., 1999)
Gsh2 (LGE)
(Corbin et al., 2000) 
Ascl1
(Casarosa et al., 
1999; Horton et al., 
1999)
Dlx1/2
(Anderson 
et al., 1997a; 
Anderson et 
al., 1997b)
??
Midbrain
Shh: Nkx2-2, Nkx6-1, 
Pax7
(Agarwala et al., 2001; 
Blaess et al., 2006)
Ascl1
(Miyoshi et al., 
2004)
(II)
Helt
(Guimera et 
al., 2006b; 
Nakatani et 
al., 2007)
Gata2
(I)
Cerebel-
lum
IsO: En2
(Sgaier et al., 2007; 
Sillitoe et al., 2008)
(Ascl1, Ngn1/2)
implications from 
fate map (Kim et al., 
2008) and expression 
data (Zordan et al., 
2008)
(Pax2)
implications 
from expres-
sion data 
(Maricich 
and Her-
rup, 1999; 
Weisheit et 
al., 2006)
Ptf1a
(Hoshino et al., 
2005)
Dorsal
spinal 
cord
Gsh1/2
(Mizuguchi et al., 
2006)
Ascl1 (late neuro-
genesis)
(Mizuguchi et al., 
2006)
Pax2
(Cheng et al., 
2004)
Ptf1a
(Glasgow et al., 
2005)
Lbx1
(Cheng et al., 
2005)
Ventral
spinal 
cord
Shh: Nkx6-1, Irx3
(Briscoe et al., 2000)
Ascl1
(Li et al., 2005)
Gata2
(Zhou et al., 
2000)
Tal1
(Muroyama et al., 
2005)
mutant 
phenotype 
(mouse)
molecular and /or 
morphological mispat-
terning 
of the brain domain
delayed/diminished 
GABAergic neuro-
genesis
GABAer-
gic neurons 
missing
GABAergic neu-
rons missing + 
re-specifi cation to 
glutamatergic fate
1.6.1. Forebrain
The GABAergic neuron development as a whole, starting from early specifi cation 
in progenitor domains to proper migration and connectivity in the adult structures, is 
perhaps best understood in the mammalian forebrain. In the forebrain, GABAergic 
neurons contribute to two major compartments: fi rst, they are an integral component of 
basal ganglia, which is central in motor coordination. Second, the inhibitory interneurons 
in the adult cortex and hippocampus are primarily GABAergic.
During forebrain development, the glutamatergic excitatory projection neurons are 
produced in the dorsal forebrain (also called pallium) and move radially to populate the 
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neocortical layers, while the inhibitory interneurons synthesizing GABA originate from 
the ventral forebrain neuroepithelium (subpallium) and migrate to the cortex tangentially 
(Marin and Rubenstein, 2001). The key molecules in regional patterning of ventral 
forebrain are HD proteins Nkx2-1, Nkx6-2, and Gsh2 and Dlx1/2, which establish 
genetically distinct subpallial regions (Figure 7A). Dlx1/2 also appear to be the main 
regulators of forebrain interneuron fate, as the Dlx1/2 mutant mice lack the GABAergic 
neurons from all derivatives of this brain region: striatum, cortex and olfactory bulbs 
(Anderson et al., 1997a; Anderson et al., 1997b). It has been shown in forebrain slice 
cultures that Dlx2 can activate the expression of Gad1 and Gad2, which are required 
for the function of GABAergic neurons (Stuhmer et al., 2002), as well as Arx, which 
contributes to their migration in the forebrain (Colasante et al., 2008).
The diversity of GABAergic neurons has also been fi rst noticed in the forebrain. 
Apparently, genetically distinct subpallial progenitor pools give rise to specifi c subtypes 
of inhibitory neurons as characterized by their co-neurotransmitters (parvalbumin, 
somatostatin, calretinin, calbindin and neuropeptide Y) used alongside GABA (Flames 
and Marin, 2005; Fogarty et al., 2007). The cortical interneuron subtypes are specifi ed 
at the time they become postmitotic, prior their migration (Fogarty et al., 2007), and 
different Dlx gene expression may contribute to their segregation, as different subtypes 
are affected in different extent in Dlx1 mutant mice (Cobos et al., 2005). 
As already mentioned, the proneural TF Ascl1 is thought to be coupled with the 
cortical GABAergic neuron fate. Ascl1 is expressed throughout the medial and lateral 
ganglionic eminences (MGE/LGE) in subpallium (Horton et al., 1999). When ectopically 
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Figure 7. Dorsoventral patterning, neuronal subtypes and tangential migration of GABAergic 
interneurons in the forebrain. Schematic representations of E14.5 mouse forebrain (coronal view 
of one hemisphere). A, Expression of HD transcription factors and proneural genes. GABAergic 
(GABA) neurons are born in ventral forebrain (MGE/LGE), glutamatergic (Glut) neurons derive 
from dorsal neuroepithelium. B, Migration routes of GABAergic neurons during forebrain 
development. Selection of proteins known to regulate interneuron migration are indicated in 
approximate relevant locations. See chapter 1.6.1a. for further details. LGE, lateral ganglionic 
eminence; MGE, medial ganglionic eminence; Ctx, cortex, Str, striatum, DA, dopamine. Modifi ed 
from Hernandez-Miranda et al., 2010; Heng et al., 2007.
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expressed in pallial neuroepithelium, Ascl1 can induce the expression of GABAergic 
markers (Fode et al., 2000). However, in the Ascl1 defi cient mice, GABAergic neurons 
can still be produced from the LGE, but not from MGE in the subpallial neuroepithelium 
(Casarosa et al., 1999). Therefore, Ascl1 seems to be suffi cient, but only region-specifi cally 
required for GABAergic neurogenesis in forebrain. Indeed, Ascl1 might be required for 
the specifi cation of certain subtypes of GABAergic neurons, while its more general 
function is to regulate the timing of the neurogenesis in the GABAergic progenitors 
via induction of Notch signalling (Casarosa et al., 1999; Yun et al., 2002). As proneural 
proteins drive neurogenic cell cycle exit, activate neuronal subtype specifi c target genes, 
and yet non-cell autonomously regulate the proliferation of adjacent progenitors, their 
function is undoubtedly complex. For example during the development of sympathetic 
chain neurons in the peripheral nervous system, Ascl1 is required in the early stage 
of neurogenesis, but this requirement can be overcome in time. It was postulated that 
other transcription factors can compensate for Ascl1, but only after reaching certain 
expression levels. At least in part, the roles of Ascl1 diverge from its proneural function 
in this context, since Ngn2 was not able to substitute for Ascl1 (Pattyn et al., 2006).
1.6.1a. Tangential migration of GABAergic neurons in the forebrain
The tangential migration in the cortex is well studied and shown to be regulated by 
wide variety of factors (Figure 7B; reviewed by Marin and Rubenstein, 2001; Marin and 
Rubenstein, 2003). Motogenic signals generally promote the interneuron migration. Such 
signals can be provided by growth factors, like Hepatocyte growth factor/Scatter factor 
(HGF/SF) that is expressed in the developing subpallium and cortical plate, adjacent 
to the interneuron migratory routes (Powell and Jarman, 2008). In the early phases 
of interneuron development, Slit1 is expressed in the VZ and SVZ of the ganglionic 
eminences (Yuan et al., 1999), and Slit-mediated repulsion is thought to guide neurons 
away from the VZ where they were born, and towards more marginal regions, affecting 
all the subpallial neurons similarly (Andrews et al., 2007; Zhu et al., 1999).
Several examples of neurotrophin signalling guiding the subpallial interneurons 
towards cortex have been described. Neurotrophins BDNF and NT-4 seem to be released 
from the developing projection neurons in the pallium, and respective TrkB receptors 
are found in migrating interneurons. The activation of downstream signalling via TrkB 
receptors promotes both the motility and migration speed of cortical interneurons 
(Polleux et al., 2002). Another neurotrophin, GDNF, via GFR1α receptor signalling is 
similarly implicated in the tangential migration of MGE-derived GABAergic neurons 
(Pozas and Ibanez, 2005). In addition, analyses of TrkB and GFR1α mutant mice 
have revealed a possibility that neurotrophin signalling might selectively regulate the 
migration of certain cortical interneuron subtypes (Canty et al., 2009; Polleux et al., 
2002). Upon reaching cortex, interneurons are distributed in different layers of the 
cerebral wall. The chemokine SDF-1 (stromal cell-derived factor-1) is expressed by the 
cortical progenitors (Tiveron et al., 2006) and implicated in the intercortical dispersion 
of GABAergic neurons, as the lack of SDF-1 or its receptor CXCR4 (expressed by the 
migrating subpallial neurons) results in abnormal distribution of GABAergic cells in 
the cortical layers (Lopez-Bendito et al., 2008; Tiveron et al., 2006). Apparently, also 
GABA signalling itself can regulate the migration of cortical interneurons. In different 
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concentrations, GABA can promote either directional or random migratory behaviour in 
cultured cells (Behar et al., 1996). Low levels of GABA are present in the developing 
forebrain (Cuzon et al., 2006). In cortical slices, depolarizing GABA-A signals promote 
interneurons to enter cortical plate (Cuzon et al., 2006), and enhance the migration 
within the cortical plate (Bortone and Polleux, 2009). The tangentially migrating MGE-
derived GABAergic neurons express GABA-B receptor, and the blockade of GABA-B 
signalling in these cells results in alterations in their migratory route and accumulation 
in the deep cortical layers (Lopez-Bendito et al., 2003). Recently, it has been shown that 
hyperpolarizing signals via GABA-A receptors can trigger the termination of interneuron 
migration in the cortical plate. The capacity to respond such signals depends on the 
maturation of interneurons and consequent upregulation of KCC2, which is responsible 
for the switch from de- to hyperpolarizing response of GABA-A activation (Bortone and 
Polleux, 2009).
However, not all the interneurons born in ventral forebrain end up in the cortex, but 
proportion of them remain to populate the GABAergic nuclei of basal ganglia, including 
striatum. Repulsive guidance molecules Sema3A and Sema3F are expressed in striatum 
during cortical development, and thus only the interneurons lacking Sema receptors, 
Neuropilins, can enter the striatum, while the neurons targeted to cortex express 
Neuropilins and avoid the source of Sema (Marin et al., 2001). In addition, dopamine 
signalling has been shown to affect subpallial interneuron migration both positively, via 
dopamine receptor D1 activation, and negatively via D2 receptor activation (Crandall et 
al., 2007).
1.6.2. Rhombomere 1
The main derivatives of the anterior hindbrain or r1 are the dorsally derived cerebellum 
along with the deep cerebellar nuclei (DCN), a set of brainstem nuclei including the 
precerebellar complex, which provides mainly excitatory input to the cerebellum; mostly 
cholinergic laterodorsal (LDTn) and peduncululopontine tegmental (PPTn) nuclei, and 
the serotonergic nuclei of dorsal raphe (Zervas et al., 2005). In addition, GABAergic 
neurons are found in many locations in the brainstem, but these populations are poorly 
characterized at present.
1.6.2a. Cerebellum
Cerebellum is a highly conserved region in the vertebrate brain, which main functions 
lay in the motor control and proprioception. There are two major neuronal subtypes in 
the cerebellum: the glutamatergic granule cells and GABAergic Purkinje, Golgi, basket 
and stellate cells. The DCN have both glutamate- and GABAergic component (Hoshino 
et al., 2005). Because of the relative simplicity of this system, the molecular regulation 
of cerebellar neurogenesis is relatively well characterized.
During development, cerebellum is derived from dorsal r1. The cerebellar GABAer-
gic cells are born from the ventricular zone of dorsal r1 (Hoshino et al., 2005), while the 
glutamatergic cells of cerebellar cortex, DCN and precerebellar nuclei originate from the 
dorsocaudal edge of the fourth ventricle, a structure called the rhombic lip (Machold and 
Fishell, 2005; Rodriguez and Dymecki, 2000; Wang et al., 2005).
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Cell lineage tracing has demonstrated that the expression of bHLH TF Ptf1a is re-
stricted to the GABAergic lineage in the cerebellum. In accordance with this expression 
pattern, Ptf1a function is central for the GABAergic neurogenesis in the dorsal r1, as Ptf1a 
mutant mice lack all cerebellar GABAergic neurons, including those in the DCN (Hoshino 
et al., 2005). It has also been shown that ectopic Ptf1a can induce the differentiation of 
cerebellar GABAergic neuron-like cells in dorsal forebrain, confi rming the master regula-
tor properties of this gene (Hoshino et al., 2005). In the absence of Ptf1a, the presump-
tive GABAergic precursors apparently adopt a glutamatergic granule cell fate (Pascual 
et al., 2007). However, because of the loss of trophic support normally provided by the 
GABAergic cells, the granule cells undergo apoptosis, eventually resulting in a complete 
loss cerebellum in the Ptf1a mutant mice (Hoshino et al., 2005; Pascual et al., 2007).
1.6.2b. GABAergic neurons in the ventral r1
Although LDTn and PPTn are mostly cholinergic nuclei, they have been found to have 
signifi cant GABAergic component (Boucetta and Jones, 2009; Wang and Morales, 
2009). LDTn and PPTn have been implicated in locomotion, nociception, pain (Lee et 
al., 2000), but also, in connection to VTA, in addiction (Ishibashi et al., 2009) or reward 
(Laviolette and van der Kooy, 2004a). However, the function and origin of the presumed 
GABAergic component in LDTn and PPTn is unknown. The Math1- expressing cells in 
the rhombic lip contribute to the precerebellar system and also to the mesopontine LDTn 
and PPTn (Machold and Fishell, 2005), but the cell type of those rhombic lip derivatives 
has not been identifi ed.
1.6.3. Spinal cord
Along the length of the spinal cord, two functional subdivisions are found at all levels: 
sensory relay circuit in dorsal part and the motor circuit in the ventral spinal cord. The 
inhibitory GABAergic neurons are integral part of both circuits, modulating both the 
sensory inputs to the CNS and the descending motor output, respectively.
1.6.3a. Dorsal spinal cord
In the dorsal spinal cord, GABAergic and glutamatergic progenitor domains are segregated 
by Notch signalling induced by the coordinate action of Ascl1 and HD family TFs Gsh1/2 
(Mizuguchi et al., 2006). Subsequently, Ptf1a is specifi cally expressed in the postmitotic 
cells in the GABAergic precursor domain, where it instructs differentiation by repressing 
the dorsal glutamatergic determinant Tlx3 (Glasgow et al., 2005; Mizuguchi et al., 2006). 
In the absence of Ptf1a, spinal cord dorsal horn sensory interneurons fail to activate the 
GABAergic differentiation markers Pax2, Lhx1/5 and Gad1, and instead are trans-specifi ed 
into a glutamatergic phenotype characteristic to the cells born in their adjacent progenitor 
domains in neural tube (Tlx3+, Vglut2+). This fate switch demonstrates dual properties of 
Ptf1a: supporting the GABAergic and suppressing glutamatergic differentiation routes 
(Glasgow et al., 2005).
1.6.3b. Ventral spinal cord
Yet other transcriptional regulators are involved in GABAergic fate specifi cation in the 
ventral spinal cord, where the progenitors of GABAergic (V2b; characterized by the 
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expression of Gata2, Gata3 and Tal1) and glutamatergic (V2a; Chx10+) interneurons 
are closely related in lineage (Karunaratne et al., 2002; Smith et al., 2002; Zhou et al., 
2000). This and adjacent progenitor domains are initially patterned by the Shh gradient 
and its target gene expression (Briscoe et al., 2000; Poh et al., 2002). Both GABA- 
and glutamatergic lineages arise from the Foxn4 and Ascl1 expressing p2 progenitor 
domain, which gives rise to V2 postmitotic precursors, characterized by the expression 
of Gata2 and Lhx3 (Karunaratne et al., 2002; Zhou et al., 2000). Early V2 precursors 
are subsequently segregated into two distinct groups by Foxn4-induced Notch1-
Delta4 signalling, which initiates the expression of V2b fate determinant Tal1 (Del 
Barrio et al., 2007; Peng et al., 2007). The V2a/b segregation is further refi ned by the 
Lim-HD transcriptional cofactor Lmo4, which mediates the formation of Gata2-Tal1 
transcriptional complex that in turn regulates Gata2/3 expression in V2b cells (Joshi et 
al., 2009). Gata2 as well as Tal1 have been shown to be suffi cient for the commitment 
to V2b phenotype (Karunaratne et al., 2002; Muroyama et al., 2005; Zhou et al., 2000). 
At the same time, the loss of Tal1 results in specifi c lack of V2b neurons (Muroyama et 
al., 2005), while in the Gata2 mutant, the whole V2 precursor population fails to develop 
(Zhou et al., 2000).
1.6.4. GABAergic neurogenesis in the midbrain
The mechanisms of GABAergic development in the midbrain have been, surprisingly, 
ignored until quite recently. Nakatani et al (2007) studied the spatial patterning relevant 
to the GABAergic neurogenesis and identifi ed seven distinct progenitor domains along 
the dorsoventral axis in midbrain neuroepithelium called m1-m7 (Figure 5) (Nakatani et 
al., 2007). From these domains, m3-m5 and, later in development also m1 and m2 give 
rise to GABAergic neurons.
Currently, the proneural gene Ascl1 (Miyoshi et al., 2004; II), bHLH-Orange domain 
transcriptional repressor Helt (Heslike, Megane; Guimera et al., 2006b; Nakatani et al., 
2007) and zink-fi nger TF Gata2 (I) appear to be the only TFs implicated in the GABAergic 
fate specifi cation in the mammalian midbrain. Both Ascl1 and Helt are expressed in the 
midbrain VZ regions associated with GABAergic neurogenesis (Miyoshi et al., 2004; 
Nakatani et al., 2007). Requirement of Ascl1 in the early development of GABAergic 
neurons has been proposed based on the absence of Gad1 (Gad67, Glutamic acid 
decarboxylase 1, essential enzyme for GABA biosynthesis) and GABA in the Ascl1 
mutants at E11.5 (Miyoshi et al., 2004). However, this study was not focusing on Ascl1 
function in detail and no later stages were analyzed for GABAergic neuron development. 
This study addressed also Helt function, and Helt overexpression was shown to promote 
GABAergic neurogenesis in Ascl1 expressing progenitors. Thus, Helt seems to act in 
concert with Ascl1 to specify GABAergic phenotype or regulate timing of GABAergic 
neurogenesis (Miyoshi et al., 2004). Analysis of Helt mutant mice has further elucidated 
the role of Helt in midbrain GABAergic neurogenesis, demonstrating requirement for 
it in certain subgroups of midbrain GABAergic neurons. Namely, the expression of 
GABAergic neuron markers Gad1/2 is absent in superior and inferior colliculi, dPAG 
and some more lateral midbrain nuclei in these mice. The lack of gross anatomical 
defects indicates that in the absence of Helt, prospective GABAergic progenitors might 
re-specify to another neuronal subtype or undergo incomplete differentiation (Guimera 
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et al., 2006b). Indeed, further analyses have shown that in the Helt mutant midbrain, most 
of the regions associated with GABAergic neurogenesis seem to produce glutamatergic 
cells expressing Pou4f1 and Vglut2 (Nakatani et al., 2007). Nakatani et al (2007) also 
proposed the mechanism of Helt function, using gain- and loss-of-function studies. 
Because of the ectopic Ngn1/2 expression in the Helt-defi cient VZ and, conversely, the 
downregulation of Ngn1/2 in the areas of Helt overexpression, they proposed that Helt 
directs the selection of GABAergic over glutamatergic fate via repression of Ngn1/2, 
which in turn promotes glutamatergic neurogenesis (Nakatani et al., 2007).
1.6.5a. Migration and maturation of midbrain GABAergic neurons
Current understanding of GABAergic neuron migration patterns in the midbrain is limited. 
Few studies concerning the migration of GABAergic neurons in the superior colliculi 
have indicated contribution of both radial and tangential migration (Tan et al., 2002; 
Tsunekawa et al., 2005). Thus far, predominantly radial distribution of tectal neurons 
has been observed after clonal labelling of cells in dorsal midbrain neuroepithelium. The 
contribution of tangential movements seems to be minor and might only contribute to the 
uniform distribution of different cell types in the later stages of development (Tan et al., 
2002). Using Gad67 promoter driven GFP, these migratory patterns were also directly 
observed in dorsal midbrain GABAergic neurons (Tsunekawa et al., 2005). This is in 
contrast to the tangential route undertaken by interneurons in the forebrain.
1.6.5b. Connectivity of midbrain GABAergic projection neurons
Midbrain GABAergic neurons project to several distant brain regions, and these 
projection patters have been described to some extent. By combining immunolabelling 
with retrograde and anterograde tracer analyses, GABAergic cells in the VTA have 
been found to send projections to PFC (Carr and Sesack, 2000) and nucleus accumbens 
(Van Bockstaele and Pickel, 1995). Recently, GABAergic tectothalamic projections 
originating from inferior colliculi have been described using similar approach (Ito et al., 
2009).
The mechanisms of axon guidance and the establishment of connectivity patterns 
of midbrain GABAergic neurons is poorly understood, most likely due to the technical 
limitations, and lack of specifi c markers which would allow separation between different 
GABAergic subpopulations.
However, the expression of several axon guidance molecules has been described 
in ventral midbain (vMB), and their functions have been evaluated in respect to vMB 
DA projections. The expression of axon guidance molecule Netrin and its receptor DCC 
have been identifi ed in the developing rat ventral midbrain and striatum (Livesey and 
Hunt, 1997) and the neurite growth in cultured vMB DA neurons has been shown to 
be regulated by Netrin1 and Slit2 (Lin et al., 2005). EphA5 and EphB1, receptors for 
repulsive guidance factors of Ephrin family, are also expressed in ventral midbrain. 
The expression of EphB1 in the SN neurons appears complementary to the EphrinB2 
expression in the SN projection target areas in striatum. Consistently, Ephrin B2 could 
suppress neurite outgrowth in SN DA neurons in a co-culture system (Yue et al., 1999). 
The prefrontal projections from medial VTA express Neuropilin2 and are guided by 
Sema3 signals (Kolk et al., 2009). It is possible that at least some of these mechanisms 
are also involved in the development of GABAergic projections in ventral midbrain.
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1.7. Serotonergic neurons in the r1
In the hindbrain, Shh, via its targets Nkx2-2 and Nkx6-1, establishes the HD code which 
defi nes the zone of, and is suffi cient for, the serotonergic neurogenesis in the ventral 
neural tube (Craven et al., 2004; Pattyn et al., 2003). The Nkx2-2+ VZ progenitors give 
rise to Lmx1b+ serotonergic precursors. Lmx1b function is required for the expression of 
serotonergic markers Pet1 and 5-HT, but not Gata3 in the r1 (Ding et al., 2003).  Proneural 
gene Ascl1 is expressed in the ventral r1, and appears to regulate both the neurogenesis 
and fate specifi cation of the serotonergic neurons, controlling the expression of Lmx1b, 
Gata3, Pet1 and 5-HT (Pattyn et al., 2004). In addition, serotonergic neurons in r1 fail 
to develop in the Gata2 mutant neural tube explant cultures, indicating the requirement 
of Gata2 in these cells (Craven et al., 2004). Furthermore, the ability of Shh to induce 
serotonergic neuron differentiation depends on functional Gata2. Gata2 is also suffi cient 
to induce ectopic serotonergic neuron development in r1, characterized by the expression 
of Lmx1b, Pet1 and 5-HT. Interestingly, this ability is restricted to r1 and does not extend 
to more caudal hindbrain, although the requirement for Gata2 still persists (Craven et 
al., 2004).
1.8. GATA transcription factors
GATA transcription factors are C4 zink-fi nger DNA-binding proteins that were fi rst 
identifi ed as direct regulators of globin gene transcription and have been since known 
as critical components of genetic cascades regulating hematopoiesis (Cantor and Orkin, 
2002). Functionally, GATA proteins act as transcriptional regulators through a consensus 
sequence (A/T)GATA(T/G) (Lowry and Atchley, 2000). Altogether, there are 6 GATA 
transcription factors found in mammals, Gata1-6. Gata4-6 regulate the heart, smooth 
muscle and endoderm development. Gata1-3 are mostly known as hematopoietic 
regulators. Of these three factors, Gata2 is the most abundantly expressed in respective 
lineages and serves as an early and essential regulator of both hematopoietic and 
endothelial development (Patient and McGhee, 2002).
1.8.1. Gata2 and transcriptional regulation of hematopoietic lineages
As GATA family TFs are highly homologous, they are all able to recognize and bind 
effi ciently the same consensus sequence. Nevertheless, GATA TFs can exert different 
and even opposing effects on the same targets and their functions are highly context-
dependent (Wozniak et al., 2008). These differences may be explained to some extent 
by the use of different cofactors. Indeed, GATA factors typically function as a part of a 
multi-protein transcription regulatory complex. GATA proteins can interact with various 
partners: Friend of GATA (FOG) family proteins Fog1 and Fog2, bHLH TF Tal1(SCL)-
E2A heterodimers, LIM-only TF Lmo2 and LIM-family cofactor NLI (Ldb1), Krüppel-
like factors (Klf1), Ets family TF PU.1, and histone modifying proteins p300/CBP 
(reviwed by Cantor and Orkin, 2002; Ferreira et al., 2005). Transcriptional cofactors can 
modulate the function of GATA TFs. For example, in cultured blood cell progenitors, 
the presence or absence of Tal1 in the Gata2 complex can defi ne the nature (i.e. 
activation or repression) of target gene regulation (Tripic et al., 2009). Similarly, Fog1, 
a cofactor directly interacting with Gata1, facilitates its DNA binding and thus mediates 
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the exchange of Gata2 for Gata1 in the promoters of their common, but differentially 
regulated targets (Letting et al., 2004; Pal et al., 2004). 
As GATA TFs themselves, their transcriptional co-effectors have been discovered 
and extensively studied in the hematopoiesis. These studies revealed the principle of 
combinatorial regulation of hematopoietic target genes and the importance of coordinate 
functions of GATA TFs Gata1 or Gata2 together with bHLH TF Tal1. Probably the best-
known GATA-Tal1 effector complex has been described by Wadman et al (1997) and 
consists of DNA-bound Gata1 or Gata2 and Tal1-E47, which are bridged by Lmo2 and 
NLI proteins (Figure 8A; Wadman et al., 1997). This complex recognizes a conserved 
Figure 8. Similar GATA-E-box binding transcriptional regulatory complex is functional during 
human and mouse hematopoiesis, CNS development and Drosophila CNS. A, Gata2-Tal1/E2A-
Lmo2-NLI complex is regulating hematopoietic gene expression in mouse and human erythroid 
cells. B, Heteromeric complex of Pannier (Pnr), Achaete-scute/Daughterless (Ac/sc, Da) and Chip 
involved in the autoregulation of Achaete (Ac) during Drosophila sensory bristle development. 
C, The Gata2-Tal1/E47-Lmo4-NLI complex is involved in the cell fate selection (V2b fate) in 
mouse ventral spinal cord interneurons. The bipartite complex consists of two such Gata2-Tal1/
E47-Lmo4-NLI units, linked via NLI-NLI interaction. Schematics are based on Wadman et al., 
1997; Ramain et al., 2000; Joshi et al., 2009.
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GATA-E-box motif (Wozniak et al., 2008), which is found in the regulatory modules of 
many genes expressed in hematopoietic as well as endothelial cells (Cheng et al., 2009). 
Furhermore, the Gata-Tal1-E47-Lmo2-NLI complex has been shown to directly regulate 
the expression of several hematopoietic genes, like glycoprotein A (Lahlil et al., 2004), 
Lmo2 (Landry et al., 2009) and Runx2 (Nottingham et al., 2007). In addition, the E-box-
GATA elements can be found from enhancers driving gene expression in other tissues, 
like Tal1 midbrain enhancer (Ogilvy et al., 2007).
1.8.2. Gata2 in the CNS
GATA TFs also have roles outside the hematopoietic system. Of the six GATA TF-s, 
Gata2 and Gata3 have been shown to be expressed in the vertebrate CNS (George et 
al., 1994; Groves et al., 1995; Nardelli et al., 1999). Elucidating the function of GATA 
TFs in the CNS has been hampered by the early lethality by E9.5-11.5 of the knockout 
animals due to severe defects in either blood (Gata2-null, Tsai et al., 1994) or heart 
development (Gata3-null, Pandolfi  et al., 1995). Therefore, these mutations only allow 
analysis of relatively early steps in neurogenesis. Nevertheless, disorganization and 
reduced thickness of neuroepithelium was observed in the Gata3 mutant mice (Pandolfi  
et al., 1995), suggesting that GATA TFs can have distinct roles later in development, 
unrelated to their function in hematopoiesis.
Nardelli et al (1999) demonstrated the expression of Gata2 and Gata3 genes in 
the pretectum, ventral midbrain, hindbrain and spinal cord of the developing CNS and 
showed that Gata2 is required for Gata3 expression in these regions (Nardelli et al., 
1999). The midbrain expression of Gata2 could be detected the earliest at E9.5, and 
Gata3 at E10.5 (Nardelli et al., 1999). However, the possible cell type specifi city of 
Gata2 expression remained ambiguous in this study. More careful analysis of cell types 
expressing Gata2 has revealed its expression in the ventral spinal cord interneurons 
(Karunaratne et al., 2002; Zhou et al., 2000), and their GABAergic sublineage (Lundfald 
et al., 2007), serotonergic neurons in rostral hindbrain (Craven et al., 2004) and motor 
neuron precursors in the more caudal hindbrain, in rhomomere 4 (Gavalas et al., 2003; 
Pata et al., 1999). In all these locations, the general rule of the expression dynamics of 
GATA TFs is that Gata2 expression shortly precedes that of Gata3. The proteins can cross-
regulate each other, supported by the presence of GATA binding sites in their promoters, 
a general feature for GATA family members (Burch, 2005). During neurogenesis, Gata2 
seems to be expressed in the late progenitor/early differentiation stage, hinting to a 
function in cell type specifi cation or neurogenic cell cycle exit.
The function of Gata2 in the context of cellular fate specifi cation has indeed been 
demonstrated in various regions of the CNS. Gain- and loss-of-function studies have 
shown that Gata2 is both required and suffi cient for ventral interneuron development 
in the spinal cord (Karunaratne et al., 2002; Zhou et al., 2000). Gata2 is also implicated 
in the development of r1 serotonergic neurons, as discussed above (chapter 1.7.). 
Functional analyses have revealed double GATA binding elements in the 5’ proximal 
region of serotonergic fate determinant Pet1 and shown that Gata2 binding to these sites 
is required for Pet1 expression (Krueger and Deneris, 2008). Thus, the function of Gata2 
in cell fate specifi cation involves direct regulation of cell type specifi c gene expression.
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It has been proposed that besides activation of cell type specifi c targets, Gata2 may 
also instruct withdrawal from cell cycle, at least in some biological context (El Wakil 
et al., 2006). In this study, forced expression of Gata2 could infl uence cell proliferation 
in the chicken spinal cord, as judged by reduction in CyclinD1 and up-regulation of 
cyclin-dependent kinase inhibitor p27 expression in Gata2-expressing cells. Also, 
downregulation of Notch1, Delta1 and Hes5 were observed upon Gata2 overexpression. 
This function was interpreted as independent of proneural activity, as the repression of 
Hes5 was observed also when proneural activity was repressed. (El Wakil et al., 2006)
1.8.3. Gata2 transcriptional complex in the CNS
The central Gata-Tal complex in blood progenitors is formed by DNA-bound Gata1 
and Tal1-E-protein heterodimer(s), which are bridged by Lmo2 and NLI (see 1.8.1.). 
Interestingly, quite similar transcriptional complex is involved in the proneural 
patterning during the sensory bristle development in Drosophila (Ramain et al., 2000) 
(Figure 8B). Drosophila Gata homolog Pannier, proneural TFs Achaete-Scute (Ac/
sc) and E2A homolog Daughterless (Da) are engaged into a transcriptional complex 
via protein-protein interactions with the bridging molecule Chip (similar to vertebrate 
Ldb/NLI). The Pannier-Ac/Sc-Da-Chip complex mediates the direct autoregulation of 
Ac/sc during sensory bristle development. Interestingly, U-shaped (Ush), homolog of 
vertebrate FOG proteins, is acting as inhibitor of this complex formation by binding 
Pannier (Ramain et al., 2000). In the mouse spinal cord, similar Gata2-Tal1-Lmo4-NLI 
complex (V2b complex) formation is required for the activation target genes and defi ning 
the GABAergic identity of V2b ventral interneurons (Joshi et al., 2009) (Figure 8C). In 
this study, also the enhancer elements containing bipartite GATA-E-box motifs were 
identifi ed in both Gata2 and Gata3 genes and shown to be the target of V2b complex 
binding (Joshi et al., 2009).
1.8.3a. Protein partners of Gata2
Notably, the expression of both Gata2 and Tal1 has been described in the chick midbrain 
(Herberth et al., 2005) around the stages of GABAergic neuron production. Also, the 
expression of Tal1 (Elefanty et al., 1999) and Tal2 (Mori et al., 1999) have been shown 
in the mouse midbrain, raising the possibility that a GATA-Tal regulatory complex 
could also participate in neuronal fate selection in this brain region. Furthermore, the 
conditional deletion of Tal1 in the CNS with Nestin-cre has been shown to result in slight 
reduction of midbrain and more pronounced loss of hindbrain GABAergic neurons 
(Bradley et al., 2006). Also Tal2 has been implicated in the brain development, although 
no cell-type specifi c role was studied (Bucher et al., 2000).
Another group of Gata interactors in midbrain may be FOG proteins, which directly 
bind GATA TFs and can regulate their activity either positively or negatively (Cantor 
and Orkin, 2005). From this family, at least Fog2 is also expressed in the midbrain (Lu 
et al., 1999).
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Aims of the study
2. AIMS OF THE STUDY
As discussed above, Gata2 has been shown to regulate neuronal subtype specifi cation 
in the developing CNS. Although the expression of Gata2 in the midbrain has been 
recognized, its cell type specifi city and function in this brain region had not been 
addressed.
With this study, we aimed to:
I)  characterize the cell lineages and developmental stages where Gata2 and Gata3 are 
expressed in the mouse midbrain and anterior hindbrain (r1);
II)  investigate the function of Gata2 in the development of midbrain and r1;
III)  study the function of Ascl1 in midbrain and r1 GABAergic neurogenesis;
IV)  study the molecular pathways involved in the GABAergic neuron development in 
midbrain and
V)  fate map the GABAergic neuron subpopulations in the mouse midbrain, focusing 
on the SNpr and VTA GABAergic neurons.
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3. METHODS
Table 2. Methods used in this study
Method Reference Publication
BrdU labelling see publications I, II, III
PCR genotyping Table 4 I, II, III
Whole-mount 
in situ hybridization (ISH) (Henrique et al., 1995) I, III
ISH on paraffi n sections (Wilkinson and Green, 1990) I, II, III
Immunohistochemistry (IHC) (Kala et al., 2008) I, II, III
combined ISH and IHC see below I, III
Statictical methods student’s t-test (two-tailed) I, III
In ovo electroporation (Nakamura and Funahashi, 2001), see below I
Tamoxifen administration (Hayashi and McMahon, 2002) III
X-gal staining (Kala et al., 2008) III
Combined ISH and IHC
ISH pre- and post- treatments were performed fi rst, according to the modifi ed protocol 
(Wilkinson and Green, 1990). After post-hybridization washes, samples were blocked in 
TNB blocking solution (TSA Biotin kit; PerkinElmer, NEL700) for 1 hour and  incubated 
with the anti-DIG-POD Fab fragments (Roche, 1:500) overnight at +4 °C.
The TSA Fluorescence Palette System kit (PerkinElmer, NEL 760) was used to 
visualize ISH signal.
After ISH signal detection, the samples were washed and IHC was performed as 
described in Kala et al (2008), except the TNB blocking solution was used for the blocking 
and antibody dilutions. For nuclear staining, the samples were incubated with DAPI 
(1:50000 in PBS) for 5 min. Slides were mounted in Mowiol.
In ovo electroporation
Fertilized Dekalb hen eggs were used in all chicken experiments. Eggs were stored at 
+12 °C until use (for max. 4 days), and placed to the incubator at +37.8 °C to reach desired 
stages. For most manipulations, 33h incubation time was used (Hamburger-Hamilton 
stage (HH) 12-14 embryos). DNA solution (fi nal concentration of 1μg/μl, supplied 
with Fast Green for visualization) was microinjected into the midbrain vesicle. For the 
electroporation, ECM 830 electroporator and GenePaddles (3x5 mm) electrodes (BTX, 
cat.no 45-0169) were used. Electroporation conditions were as follows: voltage, 20 mV; 
pulse length, 20 milliseconds (ms); pulse interval, 500 ms; 10 pulses. 
After manipulations, eggs were supplied with 1-2 ml of PBS (containing 0.25% 
Penicillin, 0.25% Streptomycin, to avoid infections), sealed with tape and placed back to 
the incubator. The embryos were harvested 24 or 48 hours later and processed for analyses.
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27
Methods
Table 3. Transgenic mouse lines used in this study
Transgenic allele Reference Publication
Ascl1KO (Mash1null) (Guillemot et al., 1993) I, II
Engrailed1-Cre (En1-Cre) (Kimmel et al., 2000) I, II, III
Foxg1-Cre (Hebert and McConnell, 2000) III
Gata2 fl ox Haugas et al., 2010, in press I, II, III
Gbx2-CreERT2 (Chen et al., 2009) III
HeltKO (MgntZ) (Guimera et al., 2006b) I
R26R (Soriano, 1999) III
Shh-Cre (Harfe et al., 2004) III
Table 4. PCR genotyping
Transgenic allele Primers (5’ - 3’) expected PCR product(s)
En1-Cre
Cre3: CGT TTT CTG AGC ATA CCT GGA
Cre5: AAT CTC CCA CCG TCA GTA CG Cre
+: 500 bpGbx2-CreERT2Shh-Cre
Foxg1-Cre
Gata2 fl ox G2-kond-F: CTT TCC ACC CTC CTT GGA TTG2-kond-R: TTT TTC CCC AAA GTC ACC TG
wt:    490 bp
fl ox:  520 bp
R26R
R1295: GCG AAG AGT TTG TCC TCA ACC
R523: GGA GCG GGA GAA ATG GAT ATG
R26F2: AAA GTC GCT CTG AGT TGT TAT
wt:   600 bp
R26-LacZ: 325 bp
Ascl1KO
Mash1-F: CCA GGA CTC AAT ACG CAG GG
Mash1ko-R: GCA GCG CAT CGC CTT CTA TC
Mash1wt-R: CTC CGG GAG CAT GTC CCC AA
wt:   600 bp
KO: 650 bp
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Table 5. ISH probes used in this study.
Mouse probes Publication Reference/ Source
Ascl1 I, II (Jukkola et al., 2006)
Corin III (Ono et al., 2007)
Delta1 II IMAGE p968BO7112D6
Fev (Pet1) I (Jukkola et al., 2006)
Gad1 (Gad67) I, II, III (Guimera et al., 2006b)
Gad2 I (Guimera et al., 2006b)
Gata2 I, III (Lillevali et al., 2004)
Gata3 I (Lillevali et al., 2004)
Gbx2 III (Trokovic et al., 2003)
Helt I (Guimera et al., 2006b)
Hes5 II Gift from I. Thessleff
Isl1 I gift from V. Pachnis
Lmx1b I gift from H. Simon
Ngn1 II IMAGE p968GO3104D
Ngn2 I, II (Jukkola et al., 2006)
Nkx2-2 I, II IMAGE clone 480100
Otx2 I, III (Acampora et al., 1997)
Pax6 I gift from P. Gruss
Pitx2 I (Guimera et al., 2006b)
Pou4f1 I gift from Siew-Lan Ang
Slc17a6 (Vglut2), I, II (Guimera et al., 2006b)
Chicken probes
cGad1 I (Cheng et al., 2004)
cGata3 I (Lillevali et al., 2007)
cNgn2 I (Matter-Sadzinski et al., 2001)
cSlc17a6 I (Cheng et al., 2004)
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Table 6. Primary antibodies used in this study.
Raised in Antigen Publication Source/ Product number dilution
guinea pig  Heslike (Helt) I, II gift from R. Kageyama 1:500
goat
HA-probe I Santa Cruz sc-805-G 1:500
Olig2 I Neuromics GT15132 1:200
mouse
BrdU I, II, III GE Healthcare RPN20AB 1:400
HuC/D I, II Molecular Probes A21271 1:500
Lim1/2 (Lhx1) I, II Developmental Studies Hybridoma Bank (DSHB) 4F2 1:10
Mash1 (Ascl1) I BD Biosciences 556604, 1:200
Nkx2-2 I, II DSHB 74.5A5 1:250
Nkx6-1 I, II DSHB F55A10 1:500
p27 II BD Transduction labs 610241 1:800
Pax6 I, II DSHB PAX6 1:100
Pou4f1 I, II Santa Cruz sc-8429 1:400
TH III Millipore MAB318 1:300
rabbit
5-HT I Immunostar 20080 1:5000
β-gal III MP Biomedicals 55976 1:1000
Active caspase3 I, II R&D Systems AF835 1:500
CyclinD1 II Lab-vision RM-9104-SO 1:400
Gata2 I, II Santa Cruz sc-9008 1:250
Lmx1a III gift from Michael German 1:750
p27 II Thermo Scientifi c Rb-006-P0 1:100
p57 I, II NeoMarkers RB-1637-P0 1:500
phospho-histone H3 I Upstate 06-570 1:500
Sox2 I, II Millipore AB5603 1:500
TH I, III Millipore AB152 1:500
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4. RESULTS
4.1. The expression of Gata2 and Gata3 in the midbrain (I)
It was previously reported that Gata2 and Gata3 are expressed in the midbrain-r1 region 
in the mammalian CNS. However, the cell type specifi city of these TFs had not been 
unambiguously demonstrated. To identify the neurotransmitter phenotype of Gata2/3-
expressing cells in midbrain, we compared Gata2 and Gata3 expression to cell type 
specifi c markers during the development of mouse midbrain and r1. These comparisons 
revealed that the expression of Gata2 and Gata3 mRNA and protein fully coincide with 
the expression of GABAergic neuron marker Gad1 and is excluded from the cell groups 
expressing a glutamatergic neuron marker Vglut2 (vesicular glutamate transporter-2). 
As in ventral spinal cord and r1, Gata2 expression precedes Gata3 in the midbrain. We 
detected Gata2 transcripts mostly in the intermediate zone of neuroepithelium (the cells 
at the border of VZ and MZ as determined by the expression of stem cell marker Sox2 
and neuronal protein HuC/D, respectively) and in scattered pattern also in the ventricular 
zone, where proliferative neuronal precursors reside. Gata3 expression in midbrain 
seems to follow Gata2 and was only detected in differentiating Gad1+ GABAergic 
neurons in the marginal zone.
Temporally, the expression of Gata2 and Gata3 starts from the ventrolateral 
midbrain, where we detected strong expression of both genes as well as Gad1 at E11.5. 
By E12.5, Gata2 and Gata3 expression is detectable also in the dorsal midbrain (m1-
m2 domains), consistent with the later onset of GABAergic neurogenesis in dorsal as 
compared to ventral midbrain (Fig. 1 in I).
In conclusion, we demonstrated that the expression of Gata2 and Gata3 both 
spatially and temporally correlates with the GABAergic neurogenesis. This expression 
pattern of Gata2 and Gata3 suggests that these factors may be involved in GABAergic 
neuron development.
4.2. Patterning of the midbrain neuroepithelium (I)
Recently, a useful DV gene expression map was published by Nakatani et al (2007). To 
identify the precise positioning of Gata2 and Gata3 in this map, we performed similar 
analysis of DV patterning genes, bHLH TFs and GATA TFs in midbrain progenitor cells 
and differentiating neurons at E11.5-E12.5.
Our expression mapping results are consistent to the model proposed by Nakatani 
et al., but provide further detail (Figure 9). We demonstrated that Gata2 and Gata3 
are expressed in the differentiating cells of all domains associated with GABAergic 
neurogenesis, m1-m5. The progenitor cells of the same regions are characterized by Ascl1 
and Helt expression. In addition, we identifi ed a previously unrecognized heterogeneity 
in m4 domain, which apparently consists of Gad1- and Gata2/3-positive domain (m4-d) 
and Gad1- negative, Pax6-positive (m4-v) domain. The m4-v is active in glutamatergic 
neurogenesis, as identifi ed by Vglut2 expression in Pax6+ cells (Supp.Fig. S1 in I), but 
unlike the rest of the glutamatergic cells in midbrain, m4-v cells do not express Pou4f1.
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In summary, the spatial mapping demonstrated that the expression of Gata2 and 
Gata3 follows the domain boundaries established in earlier stages of development by 
combinatorial TF expression. Our results also refi ned the fate map of the lateral midbrain 
(m4). 
Figure 9. The expression of HD patterning genes, bHLH TFs, GATA factors and neuronal subtype 
specifi c genes in the proliferative ventricular zone progenitors and marginal postmitotic neuron 
precursors in midbrain DV domains (m1-m7). Expanded from Fig. 8 in (I).
4.3. Gata2 and transcriptional regulators of GABAergic fate in midbrain (I, 
II)
Next, we aimed to identify the upstream molecular pathway regulating Gata2 expression 
in the midbrain. Considering the specifi city of Gata2 to the domains of GABAergic 
neurogenesis, which in turn correlate with the VZ domains expressing bHLH TFs 
involved in midbrain GABAergic neuron development (i.e. Ascl1 and Helt), we 
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analyzed Gata2 protein expression in respect to these transcription factors. Consistent 
with the mRNA expression patterns, all three proteins were coexpressed in the VZ 
progenitors. However, the immunohistochemistry (IHC) revealed notable differences in 
their expression kinetics. We found that both Helt and Gata2 are predominantly localized 
in Ascl1 expressing cells, while only few cells coexpress Helt and Gata2. In addition, 
the nuclei of Ascl1+ cells are uniformly distributed along the apical-basal width of the 
VZ, while the nuclei of Helt-expressing cells are predominantly found at the apical side 
and Gata2 at the opposite, basal side. As follows from the INM dynamics during cell 
cycle progression, Helt would be expressed either in mitotic or newly born neuronal 
progenitors/precursors. In contrast, Gata2 could be expressed either in S-phase cells 
or postmitotic neuronal precursors that are leaving VZ to differentiate in more basal, 
marginal zone. We addressed this point by analyzing the proliferation and differentiation 
status of Gata2+ cells. Gata2+ cells did not incorporate S-phase marker BrdU after a short 
BrdU pulse, arguing against the expression of Gata2 in cycling neuronal progenitors. 
Instead, we detected coexpression of neuronal differentiation marker HuC/D in many 
Gata2+ cells, supporting the hypothesis of post-mitotic onset of Gata2 expression (Fig. 
2 in I).
In summary, these results showed that Ascl1 and Helt may be expressed in the 
proliferative progenitors, whereas Gata2 expression can be detected only after the cell 
has become postmitotic, committed GABAergic precursor (Figure 10).
Figure 10. Schematic representation of Ascl1, Helt and Gata2 expression kinetics during the 
GABAergic neurogenesis in the midbrain. The proliferative VZ precursors express varying levels 
of Ascl1 and Helt. Stabilization of Ascl1 expression triggers neurogenic cell cycle exit. Helt and 
Ascl1 are coexpressed in early GABAergic precursors. As the precursors move out of the VZ 
towars MZ, Helt is downregulated and Gata2 upregulated. In the VZ-MZ border, GABAergic 
progenitors express Ascl1 and Gata2. During differentiation in MZ, Gata3 and GABAergic 
function specifi c genes Gad1/2 are expressed. Modifi ed from Zhong and Chia, 2008.
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To study the functional relevance of the discovered relationships, we analyzed 
Gata2 expression in the mouse embryos lacking Ascl1 (Ascl1KO) or Helt (HeltKO). 
As Gata2 was absent in most of the midbrain neuroepithelium in HeltKO embryos, we 
concluded that Helt is required for Gata2 expression in midbrain, excluding the most 
ventral GABAergic domain, m5. On the other hand, in Ascl1 mutant midbrains, Gata2 
expression is initiated in the ventrolateral midbrain (m3-5), but missing in dorsal regions 
(m1-2), demonstrating spatially differential requirement of Ascl1 for Gata2 expression 
(Fig. 3 in I; Fig. 4 in II). At least in m3-5, Ascl1 may act as a general regulator of 
neurogenic cell cycle exit and Helt may primarily regulate the Gata2 expression. In the 
dorsal midbrain, the presence of both Ascl1 and Helt appears to be required to activate 
Gata2 expression. However, it is possible that in the absence of Ascl1, dorsal GABAergic 
progenitors are blocked at cell cycle exit because of the lateral inhibition received from 
neighbouring glutamatergic progenitors. Thus, the Ascl1 mutant progenitors may never 
reach the stage where Gata2 would be expressed.
4.4. The function of Gata2 in GABAergic neuron development (I, III)
We next studied the role of Gata2 during the development of diencephalic, midbrain 
and r1 GABAergic neurons using conditional deletion of fl oxed Gata2 allele (Gata2 
fl ox; Maarja Haugas, Kersti Lilleväli, Marjo Salminen) with either En1-Cre (midbrain 
and r1; Kimmel et al., 2000) or Foxg1-Cre (whole brain neuroepithelium; Hebert and 
McConnell, 2000).
4.4.1. Midbrain (I)
4.4.1a. Gata2 loss-of-function
 GABAergic neurons are lost in the absence of Gata2
In the En1-Cre/+; Gata2 fl ox/fl ox (Gata2cko) embryos, we detected no expression of 
GABAergic neuron markers Gad1, Gad2 and Gata3 in the midbrain MZ at E11.5-
13.5, demonstrating a complete loss of postmitotic GABAergic neurons. At the same 
time, expression of genes associated with progenitor domain patterning and proneural 
function, such as Ascl1, Ngn2, Helt, Nkx2-2 and Nkx6-1 in the VZ, were unaffected 
(Fig.4 A-P, and Supp.Fig S3 in I).
We analyzed the Gata2cko phenotype also in the perinatal (E18.5) brains, where 
midbrain morphogenesis is more complete. The loss of GABAergic neurons persisted 
also at the later stages, as the loss of Gata3, Gad1 and mature GABAergic neuron marker 
Pitx2 could not be detected in these Gata2cko brains (Supp. Fig. S5 in I).
These results correlate well with the onset of Gata2 expression in early postmitotic 
stage and suggest that Gata2 function is crucial for the commitment to GABAergic fate.
 Apoptosis and progenitor proliferation are unaltered in the Gata2cko
Next, we investigated the possible mechanisms behind the apparent loss of GABAergic 
neurons in the Gata2cko. Despite the substantial defect in neurogenesis, the overall 
morphology of Gata2cko embryos is indistinguishable from the wild-type (wt) 
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littermates, making cell death an unlikely explanation for the loss of GABAergic neurons. 
Consistently, the number of apoptotic cells was not increased in the Gata2cko midbrains 
at E11.5 (Supp. Fig. S4 in I). Gata2 has been reported to drive cell cycle exit in chicken 
spinal cord (El Wakil et al., 2006). In the midbrain, Gata2 is expressed in the postmitotic 
neuronal precursors already in the VZ, and thus might regulate cell cycle exit. However, 
we detected no alteration in the numbers of mitotic cells and only a minor change in 
BrdU incorporation was observed in Gata2cko versus wt m3-5 neuroepithelium. Also, 
we detected no changes in the thickness of the Sox2+ progenitor layer and HuC/D+ MZ 
in the Gata2cko (Supp. Fig. S4 in I), and the VZ progenitor patterning was unaltered, as 
mentioned above.
These results showed that the cell death or alterations in the progenitor proliferation 
or neurogenic cell cycle exit could not explain the loss of GABAergic neurons in the 
Gata2cko.
 GABAergic-to-glutamatergic fate transformation in the absence of Gata2
We then considered the possibility that the loss of the GABAergic neuron markers 
would indicate an incomplete differentiation of Gata2-mutant precursor cells or a re-
specifi cation into another phenotype.
Supporting the latter hypothesis, we observed a complementary upregulation of 
glutamatergic neuron marker Vglut2 in the prospective GABAergic domains in the 
Gata2cko midbrains (Fig. 4A-D in I). Thus, Gata2 is acting as a post-mitotic selector 
gene for inhibitory as opposed to an excitatory fate, and in the absence of Gata2 all 
midbrain-derived precursors fail to activate GABAergic pathway and switch to the 
glutamatergic, Vglut2+ phenotype instead. The genetic diversity already observed in the 
progenitors domains in the midbrain VZ, is here well illustrated also within the midbrain 
GABAergic precursors. More specifi cally, we found that in the absence of Gata2, the cells 
not merely switch on the general glutamatergic neuron marker Vglut2, but specifi cally 
acquire the expression of markers characteristic for the glutamatergic precursor subtypes 
in their adjacent compartment. For example, in wt brains, the GABAergic m5 domain 
cells are Lhx1+ while their neighbouring glutamatergic cells in m6 compartment are 
Nkx6-1+. In the Gata2cko, the post-mitotic precursors in m5 domain become Nkx6-1+, 
and lose the Lhx1 expression, resembling the m6 glutamatergic cells. Similarly, the m4-v 
glutamatergic progenitor marker Pax6 expands also to the cells of m4-d (Fig. 4Q-X in I). 
In the most dorsal GABAergic domain (m3), the precursors switch on the expression of 
Pou4f1, a marker of dorsal midbrain glutamatergic neurons (Fig. 4G,H in I).
Thus, in the absence of Gata2, prospective midbrain GABAergic precursors undergo 
a fate transformation and switch to the glutamatergic differentiation programme. 
 GABAergic neurons associated with vMB DA nuclei do not require Gata2
Perhaps the most striking aspect of Gata2cko phenotype was revealed in our analysis 
of Gata2cko midbrains at prenatal stage (E18.5), where the morphology resembles 
adult organization. Despite the complete lack of GABAergic neuron production from 
the midbrain neuroepithelium at E11.5-E13.5, and the GABA-to-glutamatergic fate 
transformation in all other midbrain GABAergic nuclei at E17.5-E18.5, we detected 
apparently normal numbers of Gata3 and Gad1 expressing GABAergic neurons in the 
SNpr and VTA of the E18.5 Gata2cko brain (Fig. 7 in I).
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Considering the crucial role of Gata2 for GABAergic neuron differentiation in 
midbrain, this observation strongly indicated a distinct origin and/or developmental 
mechanisms for the VTA-SNpr GABAergic neurons.
4.4.1b. Gata2 gain-of-function
 Gata2 induces glutamatergic-to-GABAergic fate transformation
The analyses of Gata2cko phenotype revealed strict requirement of Gata2 for GABAergic 
neuron development in the mouse midbrain. When ectopically introduced to chick neural 
tube, Gata2 induces cells to acquire V2b interneuron phenotype in the ventral spinal cord 
(Karunaratne et al., 2002) and serotonergic neuron fate in the anterior hindbrain (Craven 
et al., 2004), in both cases at the expense of the neighbouring cell fates. We decided to 
test if Gata2 can similarly trigger GABAergic neuron development in the midbrain.
We fi rst compared the expression of GABA- and glutamatergic neuron markers in 
the chick and mouse midbrain. Similar to mouse, we found Helt expression in the VZ 
progenitors giving rise to Gata2, Gata3, Lhx1/2 and Gad1 -positive GABAergic neuron 
precursors in the chick midbrain. At the same time, Ngn2 was expressed on the basal side 
of glutamatergic progenitor domain identifi ed by Vglut2 expression in the MZ. Notably, 
we also observed a Gad1 negative domain in the ventrolateral chicken midbrain, a 
likely counterpart of mouse m4-v domain. As GABAergic development seems to occur 
in similar fashion in the mouse and chick midbrain, we employed the chick model to 
demonstrate effects of Gata2 overexpression to the neurogenesis in the midbrain. Using 
in ovo electroporation to deliver Gata2 expression vector in chicken dorsal midbrain, 
we showed that Gata2 can induce the expression of Gata3, Lhx1/2 and Gad1, genes 
associated with the GABAergic differentiation pathway, in the targeted areas. In the 
same areas, Vglut2 expression seemed to be downregulated (Fig. 5 in I).
Thus, the Gata2 gain-of-function analyses demonstrated that Gata2 is not only 
necessary, but also suffi cient to switch on the GABAergic neuron differentiation in 
midbrain, and suggested that the induced GABAergic neurons are specifi ed in expense 
of glutamatergic neurons.
4.4.2. Diencephalon (I, III)
In addition to the midbrain, Gata2 is strongly expressed also in the diencephalic structure 
dorsal thalamus at the time and place of GABAergic neurogenesis. However, the possible 
function of Gata2 in the diencephalon could not be addressed in the Gata2cko, since 
En1-driven Cre is not active in that region (Supp. Fig. 2 in I). Using Foxg1-Cre mediated 
recombination, we could address the function of Gata2 also in the dorsal thalamus.
The analysis of Foxg1-Cre; Gata2 fl ox/fl ox embryos revealed the loss of GABAergic 
markers Gad1 and Gata3 in the Gata2-defi cient diencephalon (Fig. 1 in III). The switch 
into a Vglut2+ glutamatergic phenotype was also observed in the respective domains (S. 
Virolainen, K. Kala, unpublished results).
These results demonstrated that similar to midbrain, Gata2 is acting as a neuronal 
subtype selection determinant in the diencephalic GABAergic neurons.
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4.4.3. Rhombomere 1 (I)
4.4.3a. GABAergic neurons
Similar to midbrain and dorsal thalamus, we detected Gata2 and Gata3 expression also 
in the domains of GABAergic neuron production in r1.
However, in contrast to the conspicuous phenotype in midbrain and diencephalon, 
the expression of Gata3, Gad1 and Pitx2 appeared completely unaffected in the r1 
GABAergic neurons in the Gata2cko (Fig. 6 and Supp. Fig. S5 in I). Thus, Gata2 is 
essential for GABAergic neurogenesis in the midbrain and diencephalon but dispensable 
for that matter in the r1. It is possible that GATA TFs are not involved in the GABAergic 
neurogenesis in the hindbrain at all, but this is perhaps unlikely since both Gata2 and 
Gata3 are strongly expressed in the respective domains in r1. Alternatively, Gata3 might 
be able to compensate for Gata2 function in the r1, but not in the midbrain.
This result exemplifi es once more the diverse mechanisms leading to the generation of 
similar cell type, the GABAergic neuron, in different (yet adjacent) brain compartments.
4.4.3b. Serotonergic neurons
Gata2 has been reported as a crucial determinant of the r1 serotonergic neuron fate 
(Craven et al., 2004). However the previous studies have been limited due to the lethality 
of ubiquitous Gata2 inactivation at E9.5 and in the study by Craven et al (2004), the 
serotonergic neuron development has been followed using in vitro cultures of the Gata2 
mutant tissue. We could test these fi ndings in a normal biological context of developing 
embryo, as Gata2cko mutation is viable.
Consistent to the results of Craven et al (2004), we were unable to detect the 
expression of any serotonergic neuron marker, including Lmx1b, Pet1 or 5-HT in the 
Gata2cko r1. In addition, we detected no expression of Gata3 in the Gata2cko serotonergic 
compartment, while it was unaffected in the GABAergic neurons (Fig. 6 in I). Therefore, 
in contrast to Craven et al (2004), we fi nd that Gata2 is required for Gata3 expression in 
the r1 serotonergic neurons.
In conclusion, we confi rmed that Gata2 is required for the serotonergic neuron 
development in r1, and showed that in addition to other serotonergic neuron specifi c 
genes, Gata2 apparently also regulates the expression of Gata3 in these cells.
4.5. The function of Ascl1 in GABAergic neuron development (II)
Another TF associated with the domains of GABAergic neurogenesis in the mouse 
midbrain is proneural bHLH protein Ascl1 (Fig. 1 in II). Failure of GABAergic neuron 
development has been reported in Ascl1KO (Miyoshi et al., 2004). However, only an 
early stage of GABAergic neuron development was analyzed in this study. Diversity in 
Ascl1 function has been observed in the mouse forebrain, where Ascl1 is required for 
GABAergic neuron production in MGE, while in LGE this requirement is not absolute 
(Casarosa et al., 1999). We have studied the requirement of Ascl1 in the midbrain and 
r1 GABAergic neurons, providing evidence of complex requirements for Ascl1 also in 
this region.
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4.5.1. Dorsal midbrain: Ascl1 required for GABAergic neurogenesis
Our analyses of the Ascl1KO phenotype show strict requirement for Ascl1 during the 
GABAergic neuron development in the dorsal midbrain (m1-2 domains). In Ascl1KO, 
Gata2 and Gad1 expression is absent from this region at E11.5-E13.5, when active 
neurogenesis takes place (Fig. 3 in II). The defective neurogenesis if followed by a 
complete loss of GABAergic neurons from the dorsal MB derivatives, SC and dPAG 
in the E16.5 embryos (Fig. 2 in II). These observations indicate that Ascl1 function 
is required for the GABAergic neurogenesis in dorsal midbrain, as has been proposed 
previously (Miyoshi et al., 2004). Also, we observed no differences in Helt expression 
in the dorsal midbrain. During normal development, Helt expression in m1-2 is initiated 
slightly later than in ventral domains (m3-5), and both in the wt and Ascl1KO, the 
characteristic salt-and-pepper pattern of Helt+ cells was obvious (Supp. Fig. 1 in II). 
4.5.2. Ventral midbrain: Ascl1 promotes the onset of GABAergic neurogenesis
In contrast to m1-m2, we fi nd Ascl1 not required for the differentiation of GABAergic 
neurons in more ventral midbrain nuclei, but rather for the timing of neurogenesis. 
The differentiation of both Gata2+ GABAergic and Pax6+ glutamatergic precursors 
was markedly delayed in the Ascl1KO as compared to the wt midbrains. At the same 
time, increased thickness of the Sox2+ progenitor cell layer indicated a general defect 
in the cell cycle exit. However, we observed a recovery in the neurogenesis by E13.5 
(Fig. 4 in II). Consistently, GABAergic neurons were not lost from prenatal ventral 
midbrain derivatives mRF and vlPAG (Fig. 2 in II). Thus, unlike in dorsal midbrain, 
ventrolateral midbrain GABAergic neurons can be produced in absence of Ascl1, but 
their differentiation seems to be initiated at a later time point. Despite the delayed onset 
of their differentiation, the m3-5 progenitors seem to be depleted at the same time in 
Ascl1KO and wt, as the thickness of progenitor cell layer (Sox2+) was similar in the 
control and Ascl1-mutant midbrains at E13.5 (Fig. 4 in II). This means that time period 
permissive of GABAergic neurogenesis might be signifi cantly shortened due to the 
initial delay in differentiation, supported by the apparent reduction in the numbers of 
GABAergic neurons found in the ventral midbrain nuclei later in development.
4.5.2a. Loss of lateral inhibition
As a proneural TF, Ascl1 is most probably involved in the lateral inhibition, via the 
activation of Delta and triggering Hes expression in the neighbouring cells. Therefore, 
we asked if alterations in Notch pathway targets and/or cell cycle regulator expression 
could contribute to the neurogenesis defects observed in Ascl1KO midbrains. Indeed, 
the absence of Ascl1 results in downregulation of Dll1 and Hes5 in the m3-5 at E11.5. 
In addition, we demonstrated upregulation of Helt in the E11.5 Ascl1KO ventrolateral 
midbrain, where nearly all VZ cells appeared to express Helt protein in contrast to the 
salt-and-pepper pattern observed in the wt m3-5, or both control and Ascl1KO dorsal 
midbrain. Strikingly however, we observed the recovery of normal Dll1, Hes5 and Helt 
expression patterns together with the neurogenesis by E13.5. It is possible that another 
proneural factor is expressed in the absence of Ascl1 in the ventrolateral midbrain. One 
candidate would be Ngn1/2, which is expressed in mutually exclusive domains in respect 
to Ascl1 in the midbrain. However, we did not observe any expansion of Ngn1/2 to the 
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Ascl1-defi cient areas in the m3-5 or upregulation of its expression in the m1-2 (Fig. 5 in 
II). The upregulation of Ngn1/2 would perhaps also be unexpected due to the maintained 
Helt expression in the Ascl1KO, as Helt acts as a repressor of Ngn-s (Nakatani et al., 
2007). To date, the mechanism behind the re-activation of Dll1 and Hes5 in the Ascl1 
defi cient m3-5 remains to be identifi ed. 
4.5.2b. Aberrant cell cycle exit in the absence of Ascl1
We also analyzed the expression of cell cycle regulators in the m3-5 domains of Ascl1KO. 
Cyclin-dependent kinase inhibitors p57 and p27 are associated with the postmitotic 
decision in the cycling progenitors. Both of these proteins were clearly expressed and 
locally even upregulated in the Ascl1KO at E11.5, showing that even at the time of 
suppressed neurogenesis, Ascl1 mutant cells are attempting cell cycle withdrawal. The 
increase in p27/p57+ cell numbers might indicate a defect in the progression from that 
particular step, for example due to incomplete instructions for differentiation. How and if 
Ascl1 regulates the onset of differentiation gene expression is unclear. Rather, it is likely 
that in the absence of Ascl1 progenitor cells can not readily acquire competence for 
differentiation. In addition, we noticed clear differences in how ventrolateral midbrain 
VZ cells tolerate the loss of Ascl1. For example, the m4 domain cells seem to be the 
earliest to recover from the differentiation arrest, since Gata2 and p27 expression is fi rst 
detected in this domain, also HuC/D seems to be expressed earlier (Fig. 6 in II).
Altogether, our analyses of the Ascl1KO phenotype in ventrolateral midbrain 
demonstrated diversity in the cellular tolerance to the loss of Ascl1. In contrast to its 
requirement for GABAergic differentiation in dorsal midbrain, the main function of Ascl1 
in the ventral midbrain seems to be to regulate the timing of GABAergic neurogenesis.
4.5.3. VTA and SNpr: Ascl1 is dispensable for GABAergic neuron development
We next looked more closely at the most ventral midbrain GABAergic neurons in the 
SNpr and VTA, which were unaffected by the loss of Gata2. In the Ascl1-mutant prenatal 
midbrains, Gad1+ GABAergic neurons in the SNpr and VTA appeared normally present. 
Unlike the other GABAergic nuclei, mRF and vlPAG, we did not notice reduction in the 
intensity of Gad1 expression in the SNpr or VTA, indicating that there is no reduction in 
the cell numbers in these nuclei (Fig. 2 in II).
Therefore, similar to Gata2, Ascl1 appears to be dispensable for the development of 
GABAergic neurons associated with midbrain DA nuclei.
4.5.4. Rhombomere 1: Ascl1 is dispensable for GABAergic neuron development
Ascl1 has also been shown to be expressed in the hindbrain. We confi rmed this, showing 
the expression of Ascl1 in the progenitor domains producing GABAergic neurons in r1 
and also in more caudal rhomobomeres. However, we did not notice defects in the Gad1 
expression in the r1 of Ascl1KO at E13.5 or E16.5. In this aspect, Ascl1KO is again 
similar to Gata2cko, where r1 GABAergic neurons are also normally present (Fig. 3 in 
II).
In summary, our analyses showed that Ascl1 is involved in the development of the 
GABAergic neurons in the midbrain, but not in the r1.
Results
39
Results
4.6. Origin of VTA-SNpr GABAergic neurons (III)
As the GABAergic neurons in SNpr and VTA are not affected by the loss of Gata2 
or Ascl1, we reasoned that these cells may originate from adjacent brain regions that 
also remain unaffected in the Gata2cko or the Ascl1KO. These regions include the 
diencephalon, which remained unaffected in the Gata2cko, and r1, where GABAergic 
neurogenesis does not require Gata2 or Ascl1 (I,II). Considering these possibilities, we 
underwent detailed fate-mapping to identify the spatiotemporal origin of the SNpr and 
VTA GABAergic neurons (vMB GABAn).
4.6.1. Normal development of vMB GABAn despite the lack of GABAergic 
neurogenesis in dorsal thalamus
As described in 4.4.2., we designed a general CNS deletion of Gata2 using the Foxg1-
Cre, which is active throughout the developing neuroepithelia. In the Foxg1-Cre; 
Gata2fl ox/fl ox brains, GABAergic neurons were missing in the diencephalic derivative 
dorsal thalamus and, consistent with the Gata2cko, also in midbrain, but unaffected in 
the r1. Importantly, we also observed normal development of vMB GABAn in these 
mutant brains (Fig. 1 in III). 
This data suggests that the origin of vMB GABAn in diencephalon is less likely than 
origin in r1.
4.6.2. Genetic fate mapping by Cre-recombinase
We utilized Cre recombinase expressing mouse lines to label cells born in distinct areas 
in R26R Cre-reporter mouse, and followed the beta-galactosidase (β-gal) expression 
in the vMB GABAergic and dopaminergic cells. With En1-Cre, we could identify 
cells originating from midbrain and r1, and vMB GABA- as well as DA neurons were 
effi ciently labelled in En1-Cre; R26R brains (Fig. 2 in III). Therefore, vMB GABAn 
originate from the MB-r1 area.
To separate cells originating from midbrain and r1, we used r1-specifi c Cre expressed 
in the Gbx2+ domain (Gbx2-CreERT2, Chen et al., 2009). CreERT2 protein expressed 
in this mouse line can be activated by tamoxifen (tx) administration. For our analyses, 
we induced Cre activity at E8.5, a stage where clear Otx2 and Gbx2 expression border at 
MHB is established (Supp.Fig, S1 in III). After tx administration, recombinase activity of 
CreERT2 persists for 36-48h (Hayashi and McMahon, 2002), allowing us to follow the 
descendants of cells expressing Gbx2 at E8.5-10.0 (10.5). Prominent β-gal expression in 
the vMB was conspicuous in the E18.5 Gbx2-CreERT2; R26R brains. Furthermore, this 
labelling was predominantly restricted to GABAergic and not DA neurons (Fig. 3 in III).
However, we observed that in addition to r1, some midbrain fl oor plate cells are 
also labelled by Gbx2-CreERT2 at E9.5 (Fig. 4 in III). As the midbrain fl oor plate has 
been reported to be neurogenic (Joksimovic et al., 2009b), the labelled cells in SN-VTA 
of E18.5 brains could be derived either from this population, or from r1. To distinguish 
between these options, we used Shh-Cre that is active in only the fl oor plate cells in r1 
(which are non-neurogenic), but in the midbrain its activity extends to adjacent basal 
midbrain cells in addition (Joksimovic et al., 2009b).  Shh-Cre effi ciently labelled DA 
cells in the ventral midbrain. In contrast, most of the GABAergic cells in the same region 
were β-galˉ (Fig. 5 in III).
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Thus, we concluded that SNpr and VTA GABAergic cells primarily do not originate 
in the ventral midbrain neuroepithelium, but instead are derived in r1, excluding its fl oor 
plate.
4.6.3. Birth-dating of midbrain GABAergic neurons by BrdU labelling
Having identifi ed the origin of vMB GABAn in the r1, we wanted to follow the timing of 
their appearance. Using BrdU-labelling over long (4-7 days prior to birth) and short time 
periods (18 hours saturation starting at different developmental stages between E9.5 
and E13.5), we determined the time point of the fi nal mitoses and the stage of the peak 
in neurogenic division for the Gad1+ cells in different midbrain areas: r1 derived SNpr, 
ventral midbrain derived mRF and dorsal midbrain derived SC.
The birth-dating analyses showed that SNpr GABAergic neurons are generated 
during E11.5-E13.5, with a peak at E11.5. Similar results of the time or origin of SN 
and VTA cells have been obtained in rat, although this study did not distinguish neuronal 
subtypes (Altman and Bayer, 1981). The timing of vMB GABAn production appears 
slightly different from the Gad1+ cells in other midbrain nuclei included in our analyses. 
In short, the ventral midbrain derived mRF neurons seem to be produced slightly earlier, 
while dorsal midbrain neurons in a later and longer-lasting wave of neurogenesis. 
The neurogenesis concerning SNpr cells is completed by E13.5, a day later than the 
ventrolateral midbrain-derived mRF, but earlier than in dorsal midbrain, where some 
GABAergic cells still seem to be generated as late as E14.5 (Fig. 6A-B in III).
Thus, the GABAergic neurons in different midbrain nuclei, including the SNpr-
VTA, are produced with distinct kinetics.
4.6.4. GABAergic neuron migration from r1 to ventral midbrain
Our birth-dating analyses demonstrated that the SNpr GABAergic neurons are produced 
during E11.5-E13.5. At these stages, no Gad1+ GABAergic neurons could be detected in 
the Gata2cko midbrains, or in the VTA or SN area, defi ned as the immediate proximity 
of TH+ cells, in the wt ventral midbrains. We again utilized Gbx2-CreERT2; R26R 
mice and were able to observe the appearance of β-gal+ and Gad1+ cells in the midbrain 
neuroepithelium. In these embryos, we detected the fi rst β-gal+ cells in vMB at E14.5. 
More β-gal+ cells are present in midbrain at E15.5, by which stage we could also detect 
fi rst Gad1+ cells in the area associated with TH+ cells both in wt and Gata2cko. By E16.5, 
GABAergic neurons clearly populate SNpr area and these cells were also labelled by 
Gbx2-CreERT2 (Fig. 6 C-R in III).
Taken together with the fate-mapping and birth-dating data, the timing of 
GABAergic neuron appearance suggests that r1-derived vMB GABAn relocate into 
their fi nal positions in VTA-SN area as post-mitotic precursors.
4.7. Gata2 binding partners (unpublished)
We next aimed to identify potential targets of Gata2 in the mouse midbrain. For this, we 
chose to compare the global gene expression in the wt and Gata2cko mouse embryos 
using a cDNA microarray.
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Overall, the results of the microarray analysis correlated well with Gata2cko 
phenotype we have described. In addition, we depicted several new candidates possibly 
involved in Gata2-mediated specifi cation of GABAergic fate. For example, GATA-
associated proteins like bHLH TFs Tal1 and Tal2, as well as FOG family members 
Fog1 and Fog2 were represented among the genes downregulated in Gata2cko. These 
TFs facilitate and modulate the function of GATA proteins. We have confi rmed the 
expression of Tal1, Tal2 and Fog2 in the regions producing GABAergic neurons in 
the mouse midbrain, and verifi ed their downregulation by ISH analysis of Gata2cko 
embryos (Figure 11).
Consistently, the regulation of Tal1 midbrain enhancer by Gata2 (and Tal1 itself) has 
been shown in the developing embryo (Ogilvy et al., 2007).
Figure 11. ISH analysis of Gad1, Tal2, Tal1 and Fog2 expression in coronal sections of wt and 
Gata2cko midbrain at E12.5.
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5. DISCUSSION
5.1. The expression of Gata2 and Gata3 in midbrain
Nardelli et al (1999) suggested Gata2 and Gata3 are expressed in the motor neurons of 
oculomotor complex in mouse ventral midbrain, probably because of the proximity of 
Gata2+ cells to the respective arc in chicken midbrain (Agarwala et al., 2001), and the 
motor neuron phenotype observed in Gata2-mutant hindbrain. However, no co-labelling 
with motor neuron markers were demonstrated in the mouse midbrain, but Isl1,Gata2 
double labelled cells were shown only in the hindbrain (Nardelli et al., 1999). In the 
more caudal regions of CNS like the spinal cord, the Gata2/3 positive cells constitute 
inhibitory GABA- or glycinergic interneurons (Lundfald et al., 2007).
We have identifi ed the neurotransmitter identity of Gata2/3 expressing cells in the 
midbrain, showing that these TFs are specifi cally expressed in the developing GABAergic 
neurons. In our studies, we have used the expression of GABA synthesizing enzymes, 
Gad1 and Gad2, to identify GABAergic identity. In addition, we fi nd that Gata3 is also a 
reliable marker of GABAergic neurons in midbrain. Recently, the coexpression of Gata3 
and GABA has also been demonstrated (Joksimovic et al., 2009a).
In addition to the subtype identity of Gata2+ cells, we showed that Gata2 expression 
is restricted to the early post-mitotic precursors that are exiting the VZ and starting to 
differentiate. Gata3 expression is regulated by Gata2 and can only be detected in the 
differentiating GABAergic neurons in the MZ. Similar expression dynamics of Gata2 
and Gata3 have been shown elsewhere in the CNS, including the hindbrain serotonergic 
neurons (Craven et al., 2004, I) and ventral spinal cord precursors (Nardelli et al., 1999; 
Zhou et al., 2000).
5.2. The expression dynamics of Ascl1, Helt and Gata2
Our comparisons of the Ascl1, Helt and Gata2 protein expression revealed substantial 
differences in their expression dynamics in the VZ. The changes in these expression 
profi les likely refl ect the different proliferation or/and differentiation status of the 
VZ cells. The BrdU incorporation analyses have shown that Ascl1 and Helt are both 
expressed in the proliferative cells (II; Miyoshi et al., 2004), while Gata2 is expressed 
only post-mitotically (I).  Ascl1+ and Helt+ cells are present in salt-and-pepper pattern in 
the VZ, which might indicate the oscillatory nature of their expression (Kageyama et al., 
2008). In addition, Helt expression seems to be cell cycle dependent, as most of the Helt+ 
cells localize near the apical surface of VZ.
Oscillatory and cell cycle dependent expression of Notch pathway components 
Delta and Hes1 has recently been observed in cortical neuronal progenitors (Shimojo et 
al., 2008). In addition, oscillations in the expression of proneural gene Ngn2 have been 
observed in the cycling neuronal progenitors. Phenomenally, the Hes1 and Ngn2 appear 
to oscillate in inverse phase (Shimojo et al., 2008). The oscillations in proneural gene 
levels can be driven by the oscillatory expression of Hes proteins in progenitor cells 
(Hirata et al., 2002). Indeed, at high levels, Hes1 represses the expression of proneural 
factors and Notch ligand Delta1 (Shimojo et al., 2008). At low levels of Hes1, proneural 
genes are derepressed and thus can reactivate Notch signalling via lateral inhibition, 
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providing a feedback loop maintaining the oscillatory nature of Hes1 gene expression. 
In this system, oscillatory proneural gene expression would fi rst need to be stabilized in 
order to drive neurogenic cell cycle exit (Kageyama et al., 2009; Shimojo et al., 2008). 
Similar to Ngn2 in forebrain, we think the stabilized Ascl1 expression could be associated 
with the earliest stage of GABAergic neuron development in midbrain, possibly denoting 
the earliest time point of neurogenic decision, and persist until the exit from VZ. Helt 
seems to be coexpressed with Ascl1 in the apical neurogenic progenitors and more readily 
downregulated at the onset of differentiation pathway. As Helt acts as a transcriptional 
repressor (Miyoshi et al., 2004) and may negatively regulate Ngn1/2, its main function 
at this step is likely the suppression of glutamatergic differentiation pathway. In this 
model, we hypothesize that Helt expression may oscillate in the cycling midbrain 
neuroepithelial cells, the cells in the Helthigh phase are potent to produce GABAergic 
neurons in the presence of Ascl1, and Helt expression is rapidly downregulated after the 
onset of differentiation. Gata2 expression is initiated in the differentiating GABAergic 
precursors, shortly after the strong Helt and Ascl1 expression wave, and its function is to 
instruct GABAergic differentiation (Figure 12).
Figure 12. The expression dynamics of Ascl1, Helt and Gata2 during the midbrain GABAergic 
neuron development. In the proliferationg progenitors, Ascl1 and Helt expression oscillates, 
probably in response to Hes-mediated inhibition cycles. During neurogenesis, Ascl1 expression 
stabilizes and Gata2 expression is initiated at the Helthigh phase, specifying a GABAergic identity 
in the newborn neuronal precursor.
5.3. Fate transformation in the Gata2cko midbrain
Gata2 participates in the neuronal subtype selection in several contexts: it is involved in 
the specifi cation of ventral interneuron precursors in the spinal cord (Peng et al., 2007; 
Zhou et al., 2000) and serotonergic neurons in the hindbrain (Craven et al., 2004), as 
well as sympathetic neuron development in peripheral nervous system (Tsarovina et al., 
2004). Gata2 is also expressed in more anterior regions of the CNS, like midbrain and 
diencephalon. We studied the function of Gata2 in these brain regions and showed that 
it acts as a post-mitotic selector gene for the GABAergic over the glutamatergic neuron 
fate in the midbrain and dorsal thalamus, but not in the r1.
Using mouse and chick models, we demonstrated that Gata2 is both required and 
suffi cient for the GABAergic neuron development. In the chicken ventral spinal cord, 
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forced expression of Gata2 can induce Gata3+ V2b fate, simultaneously suppressing 
Chx10+ V2a fate (Karunaratne et al., 2002), which represents glutamatergic neuron 
population (Lundfald et al., 2007). Similarly, we showed that Gata2 promotes GABAergic 
differentiation in the chicken dorsal midbrain cells. Consistently, in the absence of Gata2, 
the neural precursors in the mouse midbrain appear to undergo a fate transformation and 
adopt a Vglut2+ glutamatergic phenotype.
However, it is possible that the GABA-to-glutamatergic fate switch is still incomplete, 
as observed in the Helt knockout brains, where dorsal midbrain neurons lose most of 
the determinants of GABAergic neurotransmission, but maintain GABA transporter-1 
expression (Guimera et al., 2006b), simultaneously upregulating glutamatergic neuron 
markers Pou4f1 and Vglut2 (Nakatani et al., 2007). It may be expected that ectopically 
produced glutamatergic cells in the Gata2cko are not fully comparable with endogenously 
produced cells, which have undergone a consummate differentiation pathway while the 
precursors in prospective GABAergic domains have acquired a distinct competence 
during the proliferative stages in the VZ. For instance, the Vglut2+ cells in m5 MZ are 
Nkx6-1+ (alike m6 glutamatergic cells), but do not maintain Lhx1/2, which is also a 
characteristic of m6. Lhx1/2 as well as Nkx2-2 expression is maintained throughout 
the m4 in Gata2cko, similar to wt. However, these genes are uniformly expressed in 
the wt m4, and we can assume their expression involves both Gata2+ GABAergic and 
Pax6+ glutamatergic precursors. As there are no specifi c markers for m4-d precursor 
cells, it is diffi cult to assess alterations in the subtype-specifi c patterning in this domain. 
Regardless to the possible alterations in the HD gene expression, Vglut2 expression 
clearly demonstrates the glutamatergic neurotransmitter phenotype acquired by all the 
Gata2-defi cient precursor cells in midbrain.
5.4. Multiple functions of Ascl1 in the GABAergic neurogenesis
A complete requirement of Ascl1 for the midbrain GABAergic neuron development had 
been suggested previously, based on the loss of GABAergic neuron markers Gad2 and 
GABA (Miyoshi et al., 2004). However, it should be noted that from the data provided 
in that paper, one can depict Gad2-positive cells in the E11.5 Ascl1KO midbrain, most 
probably located in m5 or m4 domain (Fig. 8D’ in Miyoshi et al., 2004). Our more 
detailed analysis of the same phenotype revealed that while no GABAergic neurons are 
produced from dorsal midbrain neuroepithelium in the absence of Ascl1, GABAergic 
neurogenesis in the ventral midbrain (m3-m5 domains) is markedly delayed, but not 
abolished. Thus, in the ventral midbrain, Ascl1 seems not to specify the GABAergic 
neuron fate, but rather to control the timing of their production. Altogether, our results 
favour the hypothesis of context-dependent functions of Ascl1 in the midbrain.
Also in some other neuronal populations, it has been shown that proneural genes 
promote the initiation of neurogenesis, without being absolutely required for it. For 
example, vMB DA neurons require Ngn2 for their normal development. In absence of 
Ngn2, the neurogenesis in the vMB is delayed, but not completely abolished; resulting 
in a marked reduction in mature DA neuron numbers (Kele et al., 2006). Similar to our 
observations in Ascl1KO m3-m5, downregulation of Dll1 and Hes5 accompanies the 
initial delay in neurogenesis in Ngn2-/- vMB. However, in the vMB, Ascl1 is expressed in 
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absence of Ngn2 and appears to partially compensate for its function (Kele et al., 2006), 
a phenomenon we did not observe in the GABAergic neurogenesis in m3-m5. Another 
example of complex requirements for proneural function can be found in the development 
of the central (caudal hindbrain) and peripheral noradrenergic neurons. In the hindbrain, 
the loss of Ascl1 results in a delayed onset of noradrenergic neuron production in the 
dorsal neural tube and, subsequently, in a marked decrease in the number of neurons 
eventually produced (Pattyn et al., 2006). Notably, the expression of another proneural 
gene, Ngn2, in the Ascl1-defi cient progenitors could not rescue this delay, indicating that 
the two proneural factors may possess different activities in these cells.
As opposed to midbrain, the r1 GABAergic neurons do not require Ascl1 function, 
and develop normally in the Ascl1KO. Recently, in vitro studies have indicated that 
Ascl1 can promote GABAergic differentiation in neuronal cells derived from midbrain, 
but not from r1 cells (Jo et al., 2007). This differential competence seems to be encoded 
in the cofactors interacting with Ascl1 in these cells (Jo et al., 2007).
5.5. Comparison of Gata2, Ascl1 and Helt functions
The GABAergic phenotype observed in Ascl1KO prenatal brain greatly resembles 
HeltKO described by Guimera et al. (2006b), where the same groups of ventral Gad1+ 
cells seem to be unaffected. Also, the unaffected GABAergic neurogenesis is apparently 
associated with maintained Gata2 expression in both cases. However, there are signifi cant 
Figure 13. The genetic regulation of GABAergic and glutamatergic neuron development in 
midbrain neuroepithelium. In the m1-m2 (dorsal midbrain), both Ascl1 and Helt contribute to the 
specifi cation of GABAergic phenotype by Gata2. In m3-m4, Helt is required for Gata2 expression, 
while Ascl1 regulates the timing of neurogenesis throughout the m3-m5. The factors that regulate 
the expression of Gata2 in m5 are unknown. Glutamatergic neurogenesis is controlled by Ngn1/2 
and Pou4f1 in m1-m2 and m5. Pax6 is the earliest indicator of glutamatergic neurons in the m4.
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differences in the mechanisms affected during midbrain development by the loss Ascl1 
or Helt. First, Ngn2 never expands into the m3-5 domain in the Ascl1KO, as it happens 
in the HeltKO (Nakatani et al., 2007). Second, the timing of neurogenesis is delayed in 
the Ascl1KO, but seems to be unaffected in the Helt mutant, where Gad1 expression can 
be detected at E11.5, although clearly reduced. Third, in the absence of Helt, prospective 
GABAergic neurons undergo respecifi cation into a Vglut2+ glutamatergic fate, which is 
similar to Gata2cko, but not observed in the Ascl1KO.
In comparison to Helt or Ascl1 mutant mice, Gata2cko phenotype is clearly more 
severe, lacking dorsal as well as the ventral, mRF and vlPAG GABAergic neurons. The 
GABAergic neurons associated with the midbrain dopaminergic nuclei VTA and SN 
are the only subpopulations similarly unaffected by the absence of either Ascl1, Helt 
or Gata2. Compared to the developmental roles of proneural gene Ascl1 and Ngn1/2 
repressor Helt, Gata2 is the factor most directly linked to GABAergic fate acquirement in 
neuronal precursors. Indeed, in contrast to Ascl1 or Helt, loss of Gata2 does not affect the 
patterning, proliferation or neurogenic cell cycle exit of GABAergic progenitors, but its 
function is restricted to the neuronal subtype commitment in the early stage of precursor 
differentiation. As mentioned before, in absence of either Gata2 or Helt, GABAergic 
progenitors switch their fate to a glutamatergic pathway, however, the mechanisms of 
the fate switch appear to be different. In HeltKO, the de-repression of Ngn1/2 allows the 
specifi cation of ectopic glutamatergic progenitors. In contrast, Gata2-mediated induction 
of GABAergic differentiation may be achieved by direct transcriptional activation 
of target genes, while the repression of glutamatergic pathway is likely mediated by 
currently unidentifi ed downstream effectors.
In summary, while the requirements for Ascl1 and Helt can vary between different 
cell populations, all midbrain cells seem to exclusively depend on Gata2 in order to 
commit to GABAergic fate.
5.6. Origin of midbrain GABAergic neurons
The Ascl1KO and Gata2cko analyses provided indirect evidence of the origin of 
different GABAergic neuron subpopulations in the midbrain. The complete absence 
of GABAergic neurogenesis in Ascl1KO dorsal midbrain associated with the loss of 
d/dlPAG and SC/IC GABAergic neurons conspicuously suggests the origin of these cells 
in m1-m2 neuroepithelium, while the delayed and reduced neurogenesis in ventrolateral 
midbrain and partial loss of vlPAG and mRF GABAergic neurons indicates the origin 
of these more ventral nuclei in m3-m5 zones of midbrain. Our results also support 
the hypothesis that GABAergic neurons in the midbrain reach their fi nal position in 
adult functional structures predominantly by radial migration, consistent with previous 
observations (Tan et al., 2002; Tsunekawa et al., 2005).
5.7. Origin and migration of VTA and SNpr GABAergic neurons
The developing brain is genetically and morphologically compartmentalized and it is 
a general understanding that the neurons located in certain region originate within this 
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compartment, with few exceptions. For example, the serotonergic neurons in mouse are 
born in the anterior hindbrain, and migrate anteriorly to populate the midbrain Raphe 
nuclei later (Scott et al, 2005). Our data indicates that vMB GABAergic neurons might 
similarly provide an exception of the compartment-restriction view.
Our studies of the genetic regulation of GABAergic neuron development revealed 
a unique population within the ventral midbrain nuclei: the GABAergic neurons in 
VTA and SNpr. Even in the Gata2cko midbrains, where all other GABAergic neurons 
undergo a fate transformation, these cells were developing apparently normally. Gata2 
is required for the GABAergic neurogenesis in mb and diencephalon (I, III), but not 
in r1 (I). Furthermore, the VTA and SNpr GABAergic cells are also present in normal 
numbers in the midbrains of mice lacking either Ascl1, which is also dispensable for the 
r1 GABAergic neuron development (II), or Helt, which is expressed in mb, but not in r1 
(Guimera et al., 2006a). Therefore, we found it most likely that VTA-SNpr GABAergic 
neurons originate from the nearest unaffected compartment, r1.
Indeed, by genetic fate mapping, we identifi ed the origin of VTA-SNpr GABAergic 
neurons in the r1. We have demonstrated the distinct origins of vMB GABAn and all other 
MB GABAergic neurons, revealed by the comparison of labelling patterns of En1-Cre 
and Gbx2-CreERT2. All midbrain cells are labelled by En1-Cre, while Gbx2-CreERT2 
specifi cally labels VTA and SNpr GABAergic neurons and not other populations in the 
midbrain (Fig. 5 F,G in III). The comparison of Shh-Cre and Gbx2-CreERT2 labelling 
patterns emphasizes the distinct origin of two major classes of neurons in VTA and SN: 
the r1-derived GABA and midbrain derived DA neurons (Fig. 5 F,G in III). Notably, 
the SNpc and SNpr can be (anatomically) very differently positioned within the basal 
ganglia in different species, supporting the notion of a differential origin for these nuclei 
(Smeets et al., 2000).
We then followed the appearance of the r1-derived vMB GABAn in their fi nal 
locations. First, we determined the time frame of their production, which showed small, 
but statistically signifi cant differences compared to other GABAergic neurons in the 
midbrain. According to our birth-dating, SNpr GABAn are produced before E13.5. 
However, the fi rst stage where we could conspicuously detect Gad1+ cells in the VTA-
SNpr area, was E15.5. Thus, it seems that the r1-derived vMB GABAn reach their 
fi nal positions as post-mitotic precursors. Alternatively, these cells might migrate to 
MB already earlier and initiate the expression of Gad1 only later, when they mature in 
their fi nal position. As the appearance of Gbx2-CreERT2-labelled cells in the midbrain 
correlated with the observed Gad1 expression, we nevertheless favor the hypothesis of 
post-mitotic migration.
The cues used for the r1-MB migration of GABAergic neurons are, at present, 
completely unknown. Because of the close association of DA and GABAergic neurons 
in the ventral midbrain, and the relevance of dopamine signalling in the migration of 
forebrain GABAergic neurons (Crandall et al., 2007), it is tempting to speculate that 
dopamine signalling may regulate the migration of vMB GABAn. However, this 
hypothesis remains to be studied. 
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5.8. Protein partners of Gata2 in transcriptional regulation
TAL and FOG proteins associate with GATA TFs and modulate its transcriptional 
regulator activity (Cantor and Orkin, 2002). Similar to Gata2 (Nardelli et al., 1999), 
the expression of several Gata2 associated TFs has been recognized in the CNS. For 
example, Tal1 (Elefanty et al., 1999), Tal2 (Mori et al., 1999) and Fog2 (Lu et al., 1999) 
are expressed in the mouse midbrain. However, the cell type(s) expressing these TFs in 
midbrain has not been identifi ed. In the ventral spinal cord, Tal1 appears to be a crucial 
determinant of inhibitory V2 interneuron fate (Peng 2007).
Our comparisons of Gata2, Tal1, Tal2 and Fog2 expression in the mouse midbrain 
suggest that all these genes are induced by Gata2 in the midbrain GABAergic neurons, 
indicating that these TFs are involved at least in some aspects of GABAergic fate 
specifi cation by Gata2. Consistently, and strikingly enough, the appearance of Tal2 mutant 
mice greatly resembles Helt (and Gata2) mutant, with no gross anatomical abnormalities 
in their brains, reduced size and body weight of the young mice and premature death 
within 6-8 weeks of age (Bucher et al., 2000).
In addition to midbrain, we found that Gata2 and Tal1 are both strongly expressed 
in the r1. In contrast, Tal2 mRNA levels are near undetectable in the r1 (unpublished 
results), which may indicate a function in the establishment of differences between 
MB and r1 GABAergic neuron development. Furthermore, the very similar expression 
patterns of Gata2 and Tal2 predominantly in the basal side of VZ suggest that these TFs 
function in a similar stage of neurogenesis. It is probable that rather than a single TF, 
different transcription factor complexes regulate GABAergic neuron differentiation in 
different progenitor populations.
5.9. Conclusions and future plans
This work contributes to the understanding of the genetic regulation of GABAergic 
fate selection in the midbrain neuroepithelium. Also, my results underscore the genetic 
diversity in the mechanisms regulating GABAergic neuron development in different 
brain regions, as well as the diversity between the GABAergic neurons within a single 
compartment, the midbrain.
In the future, studies of Gata2 transcription factor complex and its target genes 
should further elucidate the mechanisms of GABAergic fate specifi cation by this TF. 
Our mRNA expression profi ling revealed several potential candidates for such studies, 
including a few potential protein partners of Gata2 in the transcriptional regulation. 
From these genes, Tal2 is perhaps of special interest as it is expressed in the intermediate 
zone between VZ and MZ, as well as in scattered VZ cells, which is highly similar to the 
pattern of Gata2 expression. Based on superfi cial observations, Tal2 mutant phenotype 
also greatly resembles Gata2 and Helt mutant, but unfortunately has remained poorly 
analyzed.
Secondly, we would like to understand the mechanisms of GABAergic neuron 
development in the ventral r1 and the relocation of GABAergic neurons from the r1 to 
midbrain. Also, the projection patterns of SNpr and especially VTA GABAergic neurons 
are currently incompletely described and would deserve greater attention.
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5.10. Implications to physiology, behaviour and psychiatric disease
In the brain, wide array of GABAergic neurons are identifi ed, differing in their use of 
co-neurotransmitters, developmental migratory patterns, fi nal localization and function in 
the adult structures. Several studies have shown that the diversity of cortical GABAergic 
interneurons is spatially and genetically encoded in the subpallial neuroepithelium (Cobos 
et al., 2005; Flames and Marin, 2005; Fogarty et al., 2007). We have provided evidence of 
diverse genetic mechanisms acting to specify spatially and functionally distinct GABAergic 
neuron populations in the midbrain and anterior hindbrain.
Besides local inhibitory interneuron function, there are prominent groups of 
GABAergic projection neurons in the midbrain. These neurons, in synergy with association 
and limbic areas, are involved in nociception, locomotion, processing of pain and aversive 
stimuli, learning, reward and addiction. Therefore, understanding the differences between 
these cell populations provides ground for more specifi c and effective approaches to the 
conditions affecting such functions. 
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SUMMARY
GABAergic neurons are implicated in various behavioural functions and psychiatric 
disease and are a major neurochemical drug targets. Midbrain GABAergic neurons are 
involved in the functions as variable as perception of visual stimuli, emotions such as fear 
and anxiety, and control of body movement. Despite the functional and pharmacological 
importance of this class of neurons, the understanding of their development is incomplete.
The aim of this work was to investigate the genetic regulation of GABAergic fate 
selection in the midbrain. We have demonstrated that a zink-fi nger transcription factor 
Gata2 is both necessary and suffi cient to induce the GABAergic differentiation in the 
midbrain, but not in anterior hindbrain. We also characterized the complex requirements 
of proneural transcription factor Ascl1 during midbrain GABAergic neuron development. 
The results of this study underscore the diversity within midbrain GABAergic neurons.
In addition, we have revealed fundamental differences in the GABAergic neuron 
production and positioning in the proximity of midbrain dopaminergic nuclei (SN and 
VTA) in comparison to all other midbrain areas. Specifi cally, we showed that the SN-
VTA region GABAergic neurons originate outside midbrain, in the anterior hindbrain 
(r1), and suggest that they populate the midbrain only as most-mitotic precursors.
Future studies should further elucidate the mechanisms of genetic and transcriptional 
regulation of GABAergic neuron development in midbrain and r1.
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